Mathematical Modelling and Statistical

Inference from Immune Response Data by Miles, Alexander S.
Mathematical Modelling and Statistical
Inference from Immune Response Data
by
Alexander S. Miles
Research Masters Thesis
Hamilton Institute
National University of Ireland Maynooth
Maynooth
Co. Kildare
August 2017
Research Supervisor: Prof. Ken Duffy
Contents
1 Summary 1
2 Review of the CD8+ T cell’s background 3
2.1 Segmentation of the immune system: Where T cells fit in . . . . . . . . . . . . . . . . . 3
2.2 Stages of an adaptive immune response: What T cells do . . . . . . . . . . . . . . . . . 6
2.3 Markers and phenotype: CD8+ T cells traits . . . . . . . . . . . . . . . . . . . . . . . . 8
2.4 Experimental procedures: Observing T cells . . . . . . . . . . . . . . . . . . . . . . . . . 9
3 Description of experiments evaluating the order of CD8+ T cell differentiation 12
3.1 History of viewpoints on CD8+ T cell differentiation . . . . . . . . . . . . . . . . . . . . 13
3.2 Experiment: [Buchholz et al., 2013] . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 17
3.2.1 [Buchholz et al., 2013] experimental setup . . . . . . . . . . . . . . . . . . . . . . 17
3.2.2 [Buchholz et al., 2013] findings . . . . . . . . . . . . . . . . . . . . . . . . . . . . 19
3.2.3 [Buchholz et al., 2013] auxiliary experiments and results . . . . . . . . . . . . . . 21
3.3 Experiment: [Kinjyo et al., 2015] . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 21
3.3.1 [Kinjyo et al., 2015] experimental setup . . . . . . . . . . . . . . . . . . . . . . . 21
3.3.2 [Kinjyo et al., 2015] findings . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 24
3.3.3 [Kinjyo et al., 2015] auxiliary experiments and results . . . . . . . . . . . . . . . 26
3.4 Experiment: [Badovinac et al., 2007] . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 27
3.4.1 [Badovinac et al., 2007] experimental setup . . . . . . . . . . . . . . . . . . . . . 27
3.4.2 [Badovinac et al., 2007] findings . . . . . . . . . . . . . . . . . . . . . . . . . . . . 28
3.4.3 [Badovinac et al., 2007] auxiliary experiments and results . . . . . . . . . . . . . 29
3.5 Experiment: [Schlub et al., 2010] . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 29
3.5.1 [Schlub et al., 2010] experimental setup . . . . . . . . . . . . . . . . . . . . . . . 30
3.5.2 [Schlub et al., 2010] findings . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 31
3.5.3 [Schlub et al., 2010] auxiliary experiments and results . . . . . . . . . . . . . . . 32
3.6 Comparing experimental systems and results . . . . . . . . . . . . . . . . . . . . . . . . 32
3.6.1 Comparing all experimental systems: [Badovinac et al., 2007], [Schlub et al.,
2010], [Buchholz et al., 2013] and [Kinjyo et al., 2015] . . . . . . . . . . . . . . . 32
i
3.6.2 Comparing results: [Badovinac et al., 2007], [Schlub et al., 2010], [Buchholz
et al., 2013] and [Kinjyo et al., 2015] . . . . . . . . . . . . . . . . . . . . . . . . . 34
3.6.3 Comparing models: [Buchholz et al., 2013] and [Kinjyo et al., 2015] . . . . . . . 37
4 Mathematical models used to interrogate the CD8+ T cell expansion phase 38
4.1 Using summary statistics to find the best fitting mathematical models . . . . . . . . . . 38
4.1.1 Motivation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 38
4.1.2 Ranking models . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 38
4.2 Bellman-Harris processes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 42
4.2.1 Description of a Bellman-Harris process . . . . . . . . . . . . . . . . . . . . . . . 42
4.2.2 Results from a Bellman-Harris process . . . . . . . . . . . . . . . . . . . . . . . . 44
4.2.3 Bellman-Harris process: The exponential case . . . . . . . . . . . . . . . . . . . . 45
4.2.4 Multi–type Bellman-Harris process . . . . . . . . . . . . . . . . . . . . . . . . . . 45
4.2.5 Results for the multi-type Bellman-Harris process . . . . . . . . . . . . . . . . . 48
4.2.6 Example of a multi–type Bellman-Harris process . . . . . . . . . . . . . . . . . . 49
4.3 How the Bellman-Harris process is used in [Buchholz et al., 2013] . . . . . . . . . . . . . 50
5 Novel adaptation the fitting method to other data sets 53
5.1 Recreating [Buchholz et al., 2013] . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 54
5.1.1 Amendments to [Buchholz et al., 2013] fitting methodology . . . . . . . . . . . . 54
5.1.2 Result of the recreation of [Buchholz et al., 2013] fitting . . . . . . . . . . . . . . 56
5.2 Adapting the model fitting methodology described in [Buchholz et al., 2013] to work
with proportional data . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 57
5.2.1 Changing objective function . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 57
5.2.2 Naive cell classification in [Buchholz et al., 2013] . . . . . . . . . . . . . . . . . . 58
5.2.3 Results of fitting to cohort data . . . . . . . . . . . . . . . . . . . . . . . . . . . . 60
5.3 Further adaptations to method . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 64
5.3.1 Changing the weighting of the objective function . . . . . . . . . . . . . . . . . . 64
5.3.2 Reducing the number of phenotypes . . . . . . . . . . . . . . . . . . . . . . . . . 65
5.3.3 Predicting the day of peak immune response . . . . . . . . . . . . . . . . . . . . 67
ii
5.3.4 Predicting the average family size . . . . . . . . . . . . . . . . . . . . . . . . . . . 68
5.3.5 Results of adaptation to other papers data . . . . . . . . . . . . . . . . . . . . . 73
6 Discussion 82
6.1 Caveats of results and assumptions of the method . . . . . . . . . . . . . . . . . . . . . 82
6.2 Further work . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 86
6.3 Conclusions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 88
Appendices 90
A [Schlub et al., 2010]’s model for division estimation 90
B Sensitivity analysis on average family size 91
C Changing assumptions in modelling 94
C.1 Changing classification of naive cells . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 94
C.2 Changing objective functions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 98
C.3 Removing transfer size adjustment . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 100
C.4 Changing the parameter boundaries . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 103
D Fitting to other data sets 105
iii
Abstract:
A hallmark of the adaptive immune response is the proliferation of pathogen-specific lymphocytes
that leave in their wake a long lived population of cells that provide lasting immunity. A subject
of debate is at which time point post infection those memory cells are produced during an adaptive
immune response. In two ground-breaking studies, [Buchholz et al., 2013] and [Gerlach et al., 2013]
introduced a new experimental method that allowed them to determine the number offspring from
individual lymphocytes in vivo at a single harvesting time point. Through the development, appli-
cation and fitting of a mathematical model, the authors of [Buchholz et al., 2013] concluded that
memory cell precursors are produced before the effector cells that clear the original pathogen, contrary
to prior understanding. Cohort level cell data in the paper [Kinjyo et al., 2015], however, challenges
that deduction. In this thesis we sought to quantitatively reconcile these two reports by adopting the
mathematical methodology of [Buchholz et al., 2013] to make it suitable for drawing inferences from
the data in [Badovinac et al., 2007], [Schlub et al., 2010] and [Kinjyo et al., 2015]. When fitting to
spleen and blood data reported in these papers, under the assumptions of the model, our conclusion is
consistent with [Buchholz et al., 2013]: memory precursor cells appear before effector cells. However,
an alternative possibility supported by the data in [Kinjyo et al., 2015] is that memory is created after
the expansion phase, a deduction not possible from the data or mathematical methods in [Buchholz
et al., 2013].
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1 Summary
This thesis focuses on a cell known as the T lymphocyte, which is part of the immune system.
We seek to provide insight into an important question of immunology: when these T cells rapidly
multiply upon infection, what order do they differentiate into their cell subtypes, known as effector
T cells and memory T cells? We do this by fitting mathematical models of possible T cell behaviour
to experimental data reported in published papers. Our scope is to look at a subgroup of T cells
known as CD8+ T cells, the definition of which is covered in the next chapter. While there are many
similarities between mouse and human immune systems, there are also many differences ([Mestas and
Hughes, 2004]) and unless otherwise stated, all information in this thesis describes murine results.
In Chapter 2 we review some of the basics of the immune system and where CD8+ T cells fit in to
it. We describe the phase rapid CD8+ T cell proliferation, how it is triggered and how it ends. We
also describe the experimental techniques used to acquire the data that we eventually use to fit the
mathematical model to.
In Chapter 3 we review some of the controversies ([Ahmed et al., 2009]) around CD8+ T cell
differentiation and discuss at two recent experiments that come to seemingly different conclusions on
the question: [Buchholz et al., 2013] and [Kinjyo et al., 2015]. We will later fit mathematical models to
the data from these papers. The authors of [Buchholz et al., 2013] used an innovative approach to the
problem, observing the CD8+ T cell expansion phase while tracking cells at a clonal level (looking at
individual families descended from one progenitor cell) to obtain clonal statistics on the observed cell
subtypes. The authors of [Buchholz et al., 2013] fit mathematical models of the expansion phase to
these data and from this they determined the precursors of memory CD8+ T cells appear before effector
CD8+ T cells. We compare this paper to another, [Kinjyo et al., 2015], because their experimental
setups are similar. The [Kinjyo et al., 2015] paper does not track statistics of CD8+ T cells at a clonal
level in this experiment, only at a cohort level (across the whole population). However, [Kinjyo et al.,
2015] provides some additional data that challenges the assumptions of [Buchholz et al., 2013], such as
distribution of cell lifetimes. From this cohort data [Kinjyo et al., 2015] suggests a qualitative effector
first model. We use data from two further experimental studies [Schlub et al., 2010] and [Badovinac
et al., 2007], with similar setups. Evidence from these papers suggest one major cause of the differences
between the [Buchholz et al., 2013] and [Kinjyo et al., 2015] results is the number of cells adoptively
transferred in their experiments, which have large effect on the properties of the expansion phase.
This in combination with [Kinjyo et al., 2015] data also sheds light on some further assumptions of the
model in [Buchholz et al., 2013], particularly the assumption that memory precursor cells first appear
in the expansion phase and not later.
In Chapter 4 we review the mathematics behind the methods that the authors of [Buchholz et al.,
2013] use to fit statistical models to the observed data. These models are known as Bellman-Harris
Processes ([Harris, 1964], Ch. 6) and we review some of their properties. We do this to adapt the
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fitting process so as to be suitable for data in other papers.
Chapter 5 contains the novel elements of the thesis’s contribution. We apply the model fitting
method described in [Buchholz et al., 2013] to its reported cohort data rather than clonal data, and
obtain the same deduction of memory precursors appearing before effectors in the expansion phase.
This gives us confidence to apply the method to data in other papers where cohort data is more readily
available. We make further changes and simplifications to the fitting method to make it appropriate
for data reported in [Badovinac et al., 2007], [Schlub et al., 2010], and [Kinjyo et al., 2015]. We also
use the data in [Schlub et al., 2010] and [Badovinac et al., 2007] to adjust for the difference between
the papers in the number of cells adoptively transferred. After these adjustments, the memory first
model gives the best fit to all data sets from the spleen and blood taken from all four papers, albeit
with questionable parametrisations in some cases, and only the memory first models give a biologically
plausible fit.
In Chapter 6 we consider some of the core assumptions of the model, for instance the assumption
that memory appears in the expansion phase and not after. We also note the possibility that some of
the observed cells characterized as early memory could instead be in the process of losing their naive
characteristics. We discuss other limitations of the thesis, such as having few observed data points for
models to fit to in some instances. We suggest further work, such as alternative models that could
evaluate the data outside the assumptions taken. Finally we review the conclusions, that under the
assumptions of the model, memory appears first, but with the caveat of heavy assumptions and fitting
to limited data.
2
2 Review of the CD8+ T cell’s background
The immune system protects the body from diseases. The immune system must neutralize threats
such as pathogens (for example viruses and bacteria), cancer cells ([Schumacher and Schreiber, 2015])
and non-living substances, such as toxins, while at the same time exercise self tolerance, i.e. not
damage friendly tissue ([Murphy et al., 2008, Ch. 1.1]). There are many components to the immune
response, and this thesis looks at a type of white blood cell known as a CD8+ T cell (CD standing
for cluster of differentiation which are molecules on the cell’s surface, the positive indicating a high
number of such molecules). T cells are a type of lymphocyte, (named so because of the high number
of them found in the lymphatic system) which seek out and destroy infected cells. T cells become
activated during infection and enter a period of fast reproduction, known as the expansion phase,
to produce a clonal army that can combat the threat ([Kaech et al., 2002b]). It is the behaviour of
CD8+ T cells during this expansion phase that this thesis focuses on.
Within this chapter we review the background of CD8+ T cells. The first section subdivides the
mature immune system into different subsystems to establish the place of CD8+ T cells within them.
The second and third section describes how T cells behave during an immune response, showing how
the expansion phase relates part of the overall immune response. The fourth section looks at some
of physical characteristics of T cells. Finally we review some of the techniques and terms used by
experiments in papers, the data from which we use in our analysis. If the reader is familiar with
immunological theory and experimental concepts this chapter can be skipped.
2.1 Segmentation of the immune system: Where T cells fit in
The immune system is often segmented into innate and adaptive subsystems (Figure 1).
The cellular part of the innate immune system recognizes threats by detecting molecular patterns
common to pathogens ([Murphy et al., 2008, Ch. 2.1]). The innate system responds quickly, defeating
most threats within a few hours or days, whereas the adaptive system usually takes seven-eight days to
remove a threat, and because of this, the innate immune system deals with the majority of infections
before they cause a response from the adaptive immune system. However, the innate system does not
improve its response to a secondary infection ([Murphy et al., 2008, Ch. 2.1]).
The innate system’s cellular component includes phagocyte cells that engulf targeted cells. Phago-
cytes in turn have subtypes, two of which are dendritic cells and macrophages, which have an ad-
ditional role in helping activate the adaptive immune response ([Murphy et al., 2008, Ch. 1.3]). There
are many other components of the innate system, examples of which are: mast cells which release
histamine, to cause inflation, dilation of the blood vessels and attract more cells to combat the threat
and anatomical barriers which block the pathogens path and include skin and internal membranes.
The adaptive immune system is present in all jawed vertebrates (it has a different form in
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jawless vertebrates, [Alder et al., 2005]). Factors that distinguish it from the innate system include
the ability to improve the response upon a threat reappearing and any two sampled cells from the
adaptive system are likely to be specific to different threats. The adaptive immune system is split into
its two most important components B cells and T cells, together called lymphocytes (some other
lymphocytes, such as the natural killer cell belong to the innate immune system, these kill tumours
and virus infested cells, [Alberts et al., 2002, Ch. 22]).
An antigen (antibody generator) is any substance that can trigger an adaptive immune response
([Alberts et al., 2002, Ch. 24]). These antigens are found on the surface of harmful cells, floating
freely in the blood plasma or on certain kinds of host cells that present antigens and help induce a
immune response, which are known as antigen presenting cells ([Murphy et al., 2008, Ch. 2.10]).
A dendritic cell or macrophage are examples of an antigen presenting cell. These present antigens
sampled from its environment or taken from parts of cells engulfed via phagocytosis. Lymphocytes of
the adaptive immune response do not all respond to the same antigens, but each cell responds only to
the small repertoire that will bind with its T cell receptors (TCR) or B cell receptors (BCR),
which are different between any two cells, in a lock and key style mechanism, and thus, cells of the
adaptive immune system are referred to as antigen specific. Affinity refers to the strength of the fit
between the antigen and cell receptor and a stronger fit will be more likely to induce a strong immune
response from the cell. Although there are only a small number of cells in a mouse that will respond
to any specific antigen (est. 100-1000, [Schlub et al., 2010]) they rapidly divide to fight infection. This
mechanism, where an initially small number of cells specific to an antigen, upon infection activate and
rapidly divide is known as Clonal Selection ([Burnet, 1957]) and allows for the immune system to
respond to a wide repertoire of possible antigens and threats.
B cells provide humoral immunity by producing antibodies, Y shaped proteins that lock onto
their cognate antigen. These antibodies mark a cell for death, block the cell from functioning or cluster
cells together making them less harmful ([Alberts et al., 2002, Ch. 24])).
T cells provide cell-mediated immunity. They are categorized into two important types CD4+
and CD8+ ([Murphy et al., 2008, Ch. 1.19]). CD4+ cells, sometimes known as helper cells co-
ordinate other parts of the immune response by releasing cytokines, signal proteins recognized by
other cells ([Alberts et al., 2002, Ch. 24]). CD8+ T cells target harmful cells expressing their cognate
antigen and secrete granzyme-B, which triggers cell self-destruction in the target through a chemical
cascade, known as apoptosis. Cells that perform this action are also called cytotoxic cells. This
thesis concerns itself with CD8+ T cells ([Alberts et al., 2002, Ch. 24]).
CD8+ T cells are further categorized into naive cells, which are mature T cells that have not yet
come into contact with their cognate antigen ([Murphy et al., 2008, Ch. 8.11]) and activated T cells,
those that have. Naive cells are slow to divide and do not cause apoptosis in other cells. While the
distinction between CD8+ and CD4+ T cell and naive and activated T cells is broadly agreed upon,
there is some controversy and blurred lines around further subcategories of CD8+ activated T cells.
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Heterogeneity is observed in activated T cell populations, both at a cellular level in their behaviour
(such as the rate of proliferation and cytokine production) and physical traits (size and cell markers)
and a clonal level (i.e. family trees of T cells behave differently upon activation), while at the same
time at a population level, the immune response remains robust ([Ahmed et al., 2009], [Kinjyo et al.,
2015], [Buchholz et al., 2013], [Hodgkin et al., 2014]). It is generally agreed there are two subgroups
of activated CD8+ T cells: T cells that have the ability to induce apoptosis are called effector T cells
(TEF), these are often short lived ([Alberts et al., 2002, Ch. 24], [Ahmed et al., 2009]). T cells that
remain after the infection and have the ability to quickly mount a secondary immune response in the
case of reinfection are called memory T cells. These memory cells are of a longer lineage than their
effector counterparts. Memory cells are sometimes subdivided into effector memory T cells (TEM)
and central memory T cells (TCM, [Wherry et al., 2003]). As the name suggests, effector memory
cells sit on the overlap between the memory and effector groups, retaining some effector functionality
([Ahmed et al., 2009]), but less so than effector cells ([Schlub et al., 2010]) and these are also longer
lived than effector cells. Whereas central memory cells express CD62L and CCR7, both of which
cause the cell to home to the lymph tissue, the effector memory cells express less ([Ahmed et al.,
2009]). Thus, effector memory and central memory are distinguished by their homing tendency, with
effector memory residing in inflamed tissue, central memory residing in the peripheral lymphoid
tissue. Effector memory cells are less likely to proliferate upon reinfection than their central memory
counterparts ([Ahmed et al., 2009]) but may fulfil an effector role in the secondary response. Cells
that reside in the peripheral tissues, where reinfection is most likely, are called resident memory
cells and are sometimes considered separate subgroup ([Mueller et al., 2013], [Masopust and Schenkel,
2013]), however this thesis does not discuss this subgroup of memory further.
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Figure 1: Basic components of the mature immune system. Orange shaded areas are those
this thesis focuses on. A further categorization is that of lymphocytes: T cells, B cells and Natural
Killer cells. The cells in the Adaptive Immune System and the cellular part of the Innate Immune
system are known white blood cells (although mast cells and dendritic cells primarily do not reside in
the blood). The diagram is not exhaustive ([Alberts et al., 2002],[Murphy et al., 2008]).
2.2 Stages of an adaptive immune response: What T cells do
The behaviour of CD8+ T cells during an adaptive immune response is divided into four phases:
activation, expansion, contraction and memory. Figure 2 provides a representative caricature of
this response.
In order to activate and trigger a full immune response, a naive T cell requires at least two signals
([Murphy et al., 2008, Ch. 8.12], [Marchingo et al., 2014]):
• Signal 1. Cognate antigen. The T cell’s TCR must detect its cognate antigen presented on the
Major histocompatibility complex (MHC, a type of glycoprotein) on the surface of an
antigen presenting cell ([Murphy et al., 2008, Ch. 1.20]). This interaction often occurs in the
spleen or lymph nodes (Table 1). The antigen signal is all that is necessary for activation, but
without the other signals, it triggers a weak immune response.
• Signal 2. Co-stimulation. This comes from the antigen presenting cell via expression of molecules
such as CD80, CD86 or CD70 which bind to CD28 or CD27 on the T cell surface ([Murphy
et al., 2008, Ch. 8.12, 8.14]).
• Signal 3. Detection of cytokines. For example the cytokine interleukin-12 (IL-12), although
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other combinations could also produce a response ([Murphy et al., 2008, Ch. 8.12], [Marchingo
et al., 2014]).
To launch a substantial response signal one is necessary and either signal two or three are required in
addition. If the T cell receives deficient stimulation it may not activate or activate but trigger only
a weak immune response. During the expansion phase, the strongly activated T cells secrete further
cytokines, for example interleukin-2 (IL-2), which induces further proliferation and differentiation
of other T cells.
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threat, 90-95% of T cells 
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activated.
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Infection
6. Upon reinfection memory cells 
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Figure 2: Non-data schematic of CD8+ T cells at different stages of the immune response.
Adapted from [Kaech et al., 2002b].
.
In order to fight the infection, the small number of antigen specific T cells rapidly divide, and can
in some cases reach upwards of 10,000 fold its initial number ([Schlub et al., 2010]) depending on
the strength of activation. This is known as the expansion phase. Cells change their surface markers
and behaviour during the expansion phase when compared to their naive counterparts. For example,
cells increase in size, increase their expression of CD44 and decrease their expression of CD62L,
([Murphy et al., 2008, Ch. 10.16], [Kinjyo et al., 2015], [Buchholz et al., 2013], [Schlub et al., 2010]).
The mechanisms that drive T cell expansion are not fully understood. One possible candidate for
regulating this phase is Myc, a transcription factor (a protein that converts DNA to RNA), that
has its levels set after activation and which may decide the number of divisions a cell goes through
([Heinzel et al., 2017], [Man and Kallies, 2015]).
The contraction or death phase occurs after the expansion has ended, when the threat has been
removed and about 90-95% of the T cells created during the expansion phase die off ([Schlub et al.,
2010]). However, a pool of memory cells remain after the expansion phase has ended, and these
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respond with greater effectiveness in case of re-infection. These memory cells are quicker to respond
upon antigen detection (division, differentiation and production of cytokines) and also start from a
more numerous baseline (100-1000 fold above the initial frequency) than the naive cells that fought
the primary infection ([Murphy et al., 2008, Ch. 10.16]).
Body part Relevance to T cells Background information
Bone Marrow Produces immature native double
positive (CD8+ CD4+) T cells from
haematopoietic stem cells.
Haematopoiesis, blood cell cre-
ation ([Alberts et al., 2002, Ch. 24]).
Part of the primary lymphoid tis-
sues.
Thymus Allowing double positive T cells to
reach maturity as either CD8+ or
CD4+ naive T cells. Removes harm-
ful and useless T cells.
Haematopoiesis of T cells ([Alberts
et al., 2002, Ch. 24]). Part of the
primary lymphoid tissues.
Spleen Holds a large number of T lympho-
cytes. T lymphocytes get activated
here by antigen presenting cells.
Immunity, creates antibodies
and removes antibody covered
pathogens, filters and recycles the
bloods. ([Murphy et al., 2008, Ch.
1.15]). Part of the secondary
lymphoid tissue.
Lymph Nodes (Sec-
ondary lymphoid
tissues)
T lymphocytes get activated here
by antigen presenting cells. Acts as
transportation for T cells.
Immunity, filters the blood ([Mur-
phy et al., 2008, Ch. glos.]).
Mesenteric lymph nodes
(MLN) are the largest lymph
nodes and found in the intestine.
Part of the secondary lymphoid
tissue.
Blood Transport for T lymphocytes. Transport of resources around the
body ([Alberts et al., 2002, Ch. 22]).
Peripheral tissues
and/or site of
infection
Mature effector T cells reside here
to fight infection. Later residential
memory T cells remain here to fight
reinfection.
For example, lungs in the case of a
flu virus ([Pan et al., 2017]).
Table 1: Relevance of organs and locations in the body and with respect to T cells.
2.3 Markers and phenotype: CD8+ T cells traits
A phenotype is a segregation of a group of cells by their observable characteristics ([Alberts
et al., 2002, Ch. 24]). For example, cell size, expression of molecules on the cell surface or fluorescent
reporters. We often wish to segregate cells by their functions or potential functions and we refer to these
as different cell types or cell subsets. A common issue in immunology is accurately partitioning cells
into cell types from information on their phenotype. When a phenotype correlates with a cell-type,
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we say the phenotype purifies or enriches for that cell-type. Gating is the discrete categorization
of cells based on their surface markers, the most simple categorization is be decided by being over
or under a threshold (gate), which can be non linear if looking at multiple phenotypic traits. Table
2 shows some phenotypic traits of T cells against their proposed cell-type and these are used in the
experiments we discuss.
While the cell-type is defined by a cell’s functionality ([Wherry et al., 2003], [Sarkar et al., 2007]),
in some literature it is defined by a cells markers ([Kinjyo et al., 2015], [Buchholz et al., 2013]). This
sometimes leads to an issue in the field immunology of unaligned definitions. This thesis assumes
CD62L markers to be a good indicator of memory functionality, but we note that fitting mathemat-
ical models the differentiation of markers is not the same as fitting directly to the differentiation of
functionality.
2.4 Experimental procedures: Observing T cells
Experiments are said to be in vivo (within the living) if they observe biological phenomenon within
the whole living organism. In vitro (within the glass) refers to experiments observing a phenomenon
in a controlled environment outside the body ([Alberts et al., 2002, Ch. glos.]).
Flow cytometry is a method of observing properties of cells, such as the expression of markers on
the cells surface or measuring cell size ([Murphy et al., 2008, Ch. A-22]). This is done by suspending
cells in fluid and quickly passing them through beams of light. The cell’s surface markers are indicated
by the refraction of light passing through dye molecules bound to them. Flow cytometry can be used
to purify cells with certain characteristics to be used in experiments, this is known as Fluorescence-
activated cell sorting (FACS) or flow cytometry can evaluate cells harvested at the end of an
experiment.
Mice are often bred or genetically engineered for special properties related to the experiment.
Transgenic means that an organism has artificially introduced or removed DNA in its genetic code
([Alberts et al., 2002, Ch. 8]). Sometimes mice are cross-bred with other mice so that their offspring
acquire desired properties. In these experiments Black-6 mice (C57BL/6) are often used, a specific
strain of laboratory mouse. OT-1 mice are mice genetically engineered so that all their T cells are
specific to the SIINFEKL antigen (an antigen from chicken ovalbumin, OVA), allowing researchers
to introduce pathogens expressing OVA and induce a controlled immune response ([Kinjyo et al.,
2015],[Buchholz et al., 2013]). When introducing a pathogen to a host, it is not always possible to
have an exact count of the pathogen introduced, so the concentration of pathogens is often measured by
their visible effect: colony-forming units (cfu) are the counted number of colonies a substance makes
when applied to agar plates ([Sieuwerts et al., 2008]). Plaque forming units (pfu) is a measure of
the visible zones of infection (plaques) a substance makes in a layer of host cells ([Cammack et al.,
2006]).
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A common tool used in in vivo immunology experiments is adoptive transfer, where cells are
taken from a donor and transferred to a host. This is combined with breeding techniques so that
progeny of host cells have distinguishing cell markers from the donors, and thus can be distinguished
by flow cytometry after extraction.
Time lapse imaging/ microscopy is a technique to observe cells over time where images of the
experiment are taken at intervals. An example of this in immunology is images being recorded of cells
proliferating in wells.
Carboxyfluorescein succinimidyl (CFSE) is a fluorescent dye used to stain cells so that that
they are fluorescent under specific light frequencies ([Lyons and Parish, 1994]). As a cell divides, the
dye is divided equally between its progeny, so that the intensity of fluorescence from a cell can be used
to estimate the number of divisions between the observed cell and the dyes introduction. Cell-trace
violet (CTV) is a similar dye using a different light spectrum which has the advantage it can be used
in conjunction with ubiquitous GFP (green fluorescent protein) reporters.
Mice can been genetically engineered so that their cells express Fluorescent ubiquitination-
based cell cycle indicator, (FUCCI, [Sakaue-Sawano et al., 2008]). Cells from such mice be-
come reversibility fluorescent in either mKusabira-Orange 2 (mKO2, orange) or mAzami-Green
(mAG, green) under the appropriate frequency of light, and this fluorescence is determined by the
stage of the cell life-cycle. Cell that are mKO2+mKO2- are more likely to be quiescent (not divid-
ing). Other combinations of fluorescence (mKO2-mKO2-, mKO2-mKO2+ mKO2+mKO2+) indicate
the cell is at some stage of division. This information can be used to gage how quickly a population is
proliferating.
Sometimes an experimental setup allows for the cells being observed to be identified as being
descended from the same initial naive cell, i.e of the same family. When this is the case we use the
convention throughout of saying the data are available at a clonal or family level. If these data are
not available we say the data are at a cohort or population level.
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Cell Marker/Trait Role Purifies for...
CD4 Assists with activation. Very low in cytotoxic cells, very high in helper
cells.
CD8 Assists with activation. Very high in cytotoxic cells, very low in helper
cells.
CD62L Causes cells to home to sec-
ondary lymphoid tissues.
High in central memory and naive cells. Low on
effector and effector memory cells ([Kinjyo et al.,
2015], [Buchholz et al., 2013]).
CD27 Co-stimulation. Binds to
CD70.
High on central memory and effector memory, low
on effector cells. Expressed on naive cells but it
is unclear if this can be used to identify them.
(Hendriks et al. [2000], Baars et al. [2005], [Kinjyo
et al., 2015], [Buchholz et al., 2013]).
CD127 IL-7 receptor High on naive, central memory and effector mem-
ory cells. Low on effector cells. ([Schlub et al.,
2010]).
CD44 Activation and homing. Low values indicate naivety ([Kinjyo et al., 2015],
[Buchholz et al., 2013]).
CD45 Unknown. In experiments cells are engineered to give dif-
fering expressions to allow T cell lineages to be
distinguished([Murphy et al., 2008, Ch. App II]).
CD90 (Also known as
Thy-1)
Augments signalling. In experiments cells are engineered to give dif-
fering expressions to allow T cell lineages to be
distinguished ([Murphy et al., 2008, Ch. App II]).
CCR7 Causes cells to home to sec-
ondary lymphoid tissues.
High in central memory and low in effector mem-
ory ( [Sallusto et al., 1999]).
Cell size N/A Effector cells are larger, memory and naive cells
are smaller ([Kinjyo et al., 2015]).
Speed of division N/A Higher speeds of division in effector cells ([Kinjyo
et al., 2015], [Buchholz et al., 2013]).
Interleukin-2 (IL-2)
production
Helps T cells activate, prolif-
erate and differentiate. En-
courages cells to differenti-
ate to effectors.
Higher production indicates memory ([Alberts
et al., 2002, Ch. 24], [Buchholz et al., 2013]).
Interferon-γ (IFN–γ)
production
Encourages macrophage ac-
tivation and expression of
MHC molecules.
Indicates multifunctional cells ([Buchholz et al.,
2013],[Murphy et al., 2008, Ch. AppIII] )
T box transcription
factor (T-bet)
Regulates T cell develop-
ment.
Associated with effector cells ([Buchholz et al.,
2013],[Tantisira et al., 2004])
T-box transcription
factor eomesodermin
(Eomes)
Required for memory gener-
ation.
Associated with memory cells ([Buchholz et al.,
2013], [Knudson et al., 2017])
Killer-cell-lectin-
like-receptor-G1
(KLRG1)
Helps activation of T cells. Effector cell marker. ([Montufar-Solis et al.,
2017],[Buchholz et al., 2013])
Table 2: Phenotypic indicators for different T cell types.
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3 Description of experiments evaluating the order of CD8+ T
cell differentiation
During an adaptive immune response, at some time after activation, the expanding population of
CD8+ T cells becomes heterogeneous, containing a sub-population of effector cells whose offspring die
off during the contraction phase, and a sub-population of memory cells of longer lineage (see Section
2.2 for a details on the expansion phase). Many core aspects of the mechanisms that govern this
differentiation and expansion remain subject to controversy ([Ahmed et al., 2009]). Contemporary
questions discussed in the literature include:
• What CD8+ T cell categorisation of cell subtypes are most representative of the underlying
mechanics that drive the immune response and what phenotype best enriches for these cell
types?
• Upon activation, assuming there is an inherent ordering to T cell subtypes, which subtypes do
naive cells first differentiate into and is this behaviour consistent between different naive cells?
• Which T cell subtypes retain the potential to become other T cell subtypes?
• What drives the heterogeneity of CD8+ T cell behaviour? Candidates could include: type and
strength of initial activation, cytokines, the location within the body, an internal stochastic
mechanism within the cells or a combination.
• Can the answers to the above be formalised into a model, quantitative or qualitative, so as to
give a comprehensive view of the expansion phase of the immune response?
This thesis aims to answer one of the above questions. It examines the order which naive T cells
differentiate into effector and memory subsets. The questions are difficult to tackle independently. For
example, problems with cell subtype and phenotype classification have been put forward as causes of
confusion and seemingly contradictory evidence between theories ([Ahmed et al., 2009]). Likewise if
activation potency is what drives variation in CD8+ T cell behaviour, different experimental setups
may yield different results.
The following subsection gives an overview of different standpoints from past papers on the question
of T cell differentiation.
The subsections 3.2 to 3.5 review four articles reporting results from similar experimental setups:
adoptive transfer of OT-1 cells. Firstly, we examine two recent articles that come to different conclu-
sions as to the order of T cell differentiation: [Buchholz et al., 2013] and [Kinjyo et al., 2015]. [Buchholz
et al., 2013] is of interest to us because of its novel methodology of tracking cells at a clonal level and
its method of fitting a mathematical model to statistics observed from experiment. We seek to adapt
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this method to data available in other papers (which we do in Chapter 5). The experimental and ana-
lytical method described in [Buchholz et al., 2013] suggests that memory precursor cells appear before
effector cells (for an overview of the mathematical methods and models used in [Buchholz et al., 2013]
see Section 4.3). [Kinjyo et al., 2015] is of interest because of its use of generational and proliferation
speed data to give insight into the mechanics of the early days of the adaptive immune response. The
model suggested in [Kinjyo et al., 2015] is that effector cells appear before memory precursor cells.
One key difference in the experimental setup between [Buchholz et al., 2013] and [Kinjyo et al.,
2015] is the number of naive cells adoptively transferred. The papers [Badovinac et al., 2007] and
[Schlub et al., 2010] describe the effects of different adoptive transfer numbers on OT-1 experimental
results. While the focus of the papers [Badovinac et al., 2007] and [Schlub et al., 2010] is not the order
of T cell subtype differentiation, they also employ an experimental setup similar to that of [Buchholz
et al., 2013] and [Kinjyo et al., 2015] and we use these data to supplement the mathematical model
fitting later in Chapter 5.
In the last subsection we compare the different experimental setups, results and conclusions between
these four papers and suggest ways to reconcile them.
3.1 History of viewpoints on CD8+ T cell differentiation
There are many ideas and theories behind CD8+ differentiation during the expansion phase. To give
an overview of opinion we simplify the problem down to three basic versions of championed theories
(Figure 3, [Ahmed et al., 2009], [Kinjyo et al., 2015]):
• Linear Effector First Model: Naive cells first differentiate into effector cells, which proliferate.
Later in the immune response, these cells either differentiate into memory cells or continue to
proliferate as effectors before eventually dying.
• Linear Memory First Model: Naive cells first differentiate into memory cell precursors, which
proliferate and differentiate into effector cells. Once the expansion phase is completed the effector
cells die.
• Bifurcation Model: A naive cell has the potential to divide into either effector or memory
subsets which then continue to proliferate inheriting their cell-type. The effector cells die at the
end of the expansion phase while the memory cells remain.
These three theories are merely basic representations of more diverse and subtle theories. For example
the above assume three basic CD8+ cell-types (naive, effector and memory cell), however further cell-
types have been included in models ([Wherry et al., 2003]). These three models are also not exhaustive,
for example they all exclude the possibility of bidirectional differentiation (i.e. cells being able to
return to states they previously differentiated from) between cell-types.
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The Linear Effector First Model could be considered the traditional view and there are a number of
earlier papers suggesting that T cells go through an effector phase before differentiating into memory
cells ([Opferman et al., 1999],[Ahmed et al., 2009]). The issue was complicated by the observation
that some T cells had an overlap between memory and effector functionality and phenotypic markers.
This subcategory is often referred to as effector memory cells (TEMp, the p standing for precursor)
to distinguish them from effectors (TEF) and central memory cells (TCMp), but the exact role and
classification of TEMp cells remains a controversy in itself (see Section 2.3 on phenotypic identification).
There was also some early evidence that central memory appears before memory [Sallusto et al., 1999].
In 2007 the article [Chang et al., 2007] proposed asymmetric division theory to explain heterogeneity
with CD8+ T cells. This became a popular theory for explaining the variable population dynamics of
T cells families as being dependent on how naive cells are activated ([King et al., 2012]). In 2013 two
papers were published jointly in Science [Buchholz et al., 2013] and [Gerlach et al., 2013] that used
distinct systems to further address these issues. [Buchholz et al., 2013] developed a methodology of
fitting mathematical models to observed summary statistics of CD8+ T cell phenotypes and found the
Linear Memory First Model to be the best fit to observed data. We do not review the sister paper
[Gerlach et al., 2013] so closely, as the measurements they use to identify families, polymerase chain
reaction (PCR) amplification of retrovirally installed DNA tags, does not scale linearly with cell
counts, meaning the proportional data gathered is unsuitable for the fitting method we use.
Table 3 provides a non-exhaustive list of papers from the last 20 years supporting or giving insight
into the three basic theories. The papers listed as supporting theories are only a simplification. For
example [Kinjyo et al., 2015] is a article that supports the Linear Effector First Model, but accepts
that perhaps a naive cell may still have the ability to directly differentiate into a memory cell, however
this it is not a driving force behind the population dynamics.
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A subpopulation of effector cells 
differentiate into memory cells.
Effector cells continue to proliferate.Naïve cells differentiate into effector 
cells and proliferate.
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Effector cells die during 
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Figure 3: Three simplified models showing possibilities of ways CD8+ T cells differentiate
during the expansion phase. In the Linear Effector First Model, naive cells differentiate first into
effector cells and proliferate, only then do they differentiate into memory cell precursors. In the Linear
Memory First Model the reverse is true. In the bifurcation model naive cells have the potential to
become either phenotype. Models listed are not exhaustive.
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Reference Model Notes
[Opferman et al., 1999] EF Memory cells were found to be the progeny of cytotoxic effectors.
[Jacob and Baltimore,
1999]
EF The effectors that develop into memory cells can be identified in the primary
response.
[Sallusto et al., 1999] MF Separation of memory into effector memory and central memory. TCMp ap-
pears before then TEMp (human).
[Kaech et al., 2002a] - Memory cell precursors were present at the peak of the immune response but
their functional traits as memory T cells: self-renewal and rapid recall to
antigen, did not develop until later.
[Wherry et al., 2003] EF TEMp’s are the intermediate phenotype in the linear pathway. Naive → TEF
→ TEMp → TCMp.
[Bouneaud et al., 2005] - Bi-directional differentiation between TEMp and TCMs. Memory cells are
present throughout the expansion phase stage.
[Bachmann et al., 2005] - In the expansions phase the T cell population initially expresses higher levels
of CD62L+ which are down-regulated and later increase again in the death
phase.
[D’Souza and Hedrick,
2006]
- Timing of recruitment of individual T cell clones determines the population
dynamics of the subsequent immune response. Activation theory: duration
and strength of activation signal regulates differentiation.
[Masopust et al., 2006] - Memory cell phenotype differed depending on the number re-challenges and
that secondary and tertiary responses resulted in the memory CD8 T cells
with effector-like properties.
[Sarkar et al., 2007] EF Some TEMp do not progress to TCMp. The majority of TCMp’s are derived
from TEMp’s.
[Chang et al., 2007] B Activation causes the cell to split asymmetrically with the two progeny typi-
cally having different phenotypic traits that are inherited.
[Joshi et al., 2007] EF Signals from the innate immune system regulate which effector cells become
memory cells.
[Badovinac et al., 2007] - Number of cells adoptively transferred can shorten the expansion phase.
[Harrington et al., 2008] EF There are parallels to the Linear Effector First Model for CD4 T cells.
[Sarkar et al., 2008] EF IL-2 and duration of antigen stimulation define which effectors become memory
cells.
[Teixeiro et al., 2009] B Effector and memory states are separable fates, determined by differential
TCR signalling. Activation theory: duration and strength of activation signal
regulates differentiation.
[Schlub et al., 2009] EF Support that differentiation is division-linked.
[Schlub et al., 2010] EF The number of divisions a cell goes through is linked to level of CD62L. Fur-
ther evidence that the number of cells adoptively transferred can shorten the
expansion phase.
[King et al., 2012] B Activation strength above a threshold causes asymmetric division and below
the threshold leads to an abortive immune response.
[Gerlach et al., 2013] - Single cell response is not predictable and a predictable immune summary
statistics are achieved through averaging of populations.
[Buchholz et al., 2013] MF Clonal summary statistics match to the Linear Memory First Model.
[Marchingo et al., 2014] /
[Marchingo et al., 2016]
- Strength of affinity and co-stimulation can be summed to predict strength of
immune response.
[Kinjyo et al., 2015] EF An initial homogeneous population effectors after infection is later followed by
a sub-population of memory cells later.
[Heinzel et al., 2017] - Linking levels of Myc to cell expansion.
Table 3: List of papers offering evidence for the order of differentiation during the ex-
pansion phase. Model column is a suggestion of which model the article supports (EF = Linear
Effector First Model, B = Bifurcation Model, MF = Linear Memory First Model, - = Not directly
supporting one of the described models) Earlier the history of immunology, what might be called the
Linear Effector First Model was most broadly supported. In recent years asymmetric theory became
popular. More recently [Buchholz et al., 2013] suggested a Linear Memory First Model to fit best to
their data.
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3.2 Experiment: [Buchholz et al., 2013]
The paper [Buchholz et al., 2013] reported on a collection of experiments designed to determine
clonal properties of the CD8+ T cell expansion phase and then fitted models to statistics gathered from
these data. This paper was novel in its use of congenic markers allowing for cells of the same family
to be identified. The paper also describes and developed the mathematical model that we adapt and
apply to data taken from other papers that report on experiments with similar systems, but without
familial information (Chapter 5).
3.2.1 [Buchholz et al., 2013] experimental setup
Patho
gen
NaiveNaiveNaive
Flow 
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?
?
?
?
CD45-/- CD90-/-CD45-/- CD90-/-
CD90+/+ CD90+/- CD90-/-
CD45+/+
CD45+/-
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1.  Array of  8 OT-1 congenic black 6 
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2. Adoptive transfer of purified naïve 
cells from 8 donor mice to host mouse. 
1 cell is transferred per donor for 7 
mice, 100 for the 8th donor mouse.
1-12  days post 
infection
3. Host mouse is infected with 
OVA expressing pathogen 
triggering the immune 
response. 
4. At a fixed time after infection cells 
are harvested from the host mouse 
from the blood, lungs, spleen and 
lymph node.
5.FACs analysis. For observed T cells , 
the congenic markers indicate the 
family and CD62L + CD27 markers 
indicate phenotype. Thus summary 
statistics of phenotype population is 
gathered at a family level.
Analysis
Figure 4: Summary diagram of the experimental adoptive transfer setup in [Buchholz
et al., 2013]. Congenic OT-1 mice with differentiated labels are used for an adoptive transfer exper-
iment where the cell markers are used to identify cells of the same family. Harvesting was done on
day eight and 12 on 47 host mice. Similar experiments harvested cells on days one, two, three, four,
six and eight post infection but without the array of congenic markers returning data at a population
level for these time periods and also only harvesting from the spleen.
The authors of [Buchholz et al., 2013] performed an OT-1 adoptive transfer experiment. The
experimental set up enabled authors to distinguish the transferred donor progeny of multiple naive
cells within a single mouse based on unique cell surface markers, thus allowing for clonal family data
to be observed. Donor mice were engineered to they express both CD45.1 and CD90.1 markers
homozygously, heterozygously or not at all, thus allowing for nine distinguishable combinations of
markers in total (Figure 4). There were 47 black-6 host mice chosen from double heterogeneous
marker pool. For each of these host mice there were eight OT-1 donor mice, each with a different
marker. Purifying for CD44-CD8+ allowed naive cells to be extracted from the donors. For seven
of the donor mice one naive cell was transferred, and for the remaining donor mouse 100 cells where
transferred in order to observe the effects of scaling when transferring multiple cells. The host was then
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infected with 5×103 Listeria monocytogenes, a pathogenic bacteria, expressing OVA (LM-OVA).
This caused the activation of the OT-1 naive CD8+ T cells in the mice. At day eight post infection,
the cells were harvested from host mice. Cells were taken from the spleen, lymph nodes (axillary,
inguinal, brachial, cervical, lumbar, mesenteric) and lungs. The cells observed through flow cytometry
were gated into three phenotypes: the central memory precursor (TCMp; CD27+CD62L+), effector
memory precursor (TEMp; CD27+CD62L-) and effector cells (TEF; CD27-CD62L-).
The data collected was used to generate summary statistics for phenotype populations: the average
cell count per family, coefficients of variation and correlation coefficients between phenotypes. These
summary statistics were used to choose a best fitting model of immune response from a family of 304
models with different orders of differentiation between phenotypes, one way or bidirectionally. For
details of the models, the fitting and the mathematics behind it, see Chapter 4.
Other experiments described in [Buchholz et al., 2013] that harvested cell at different times post
infection and had slightly different experimental set ups. In those experiments that harvested cells
one, two, three, four, six, days post infection, the CD45 and CD90 array of surface markers was not
used, rather only one marker was used to distinguish the host from the donor cells which meant only
proportional data were available. Rather than one cell transferred per donor there was an adoptive
transfer of 10,000 OT1 cells to get proportional data in the case of cells harvested one, two, three
and four days post infection and 100 OT1 cells were transferred for the equivalent experiments that
harvested six or eight days post infection. In that experiment cells were taken from the spleen only.
This population data, along with CFSE data, was used to compare expectations against the proposed
model.
In a similar experiment, but harvesting on day 12, other indicators of phenotype were measured.
These included IL-2, IFN-γ producers, T-box transcription factor expressed in T cells (T-bet), eome-
sodermin (Eomes) and Killer-cell-lectin-like-receptor-G1 (KLRG1). While these were not included in
model fitting they were used to show phenotypic trends within the data.
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3.2.2 [Buchholz et al., 2013] findings
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Figure 5: Summary statistics reproduced from the data reported in [Buchholz et al.,
2013]. The top left graph shows the average count of cell phenotypes on day eight post infection, top
right is the coefficients of variation of each phenotype, bottom left is the correlations between phenotype
populations and bottom right is proportions of populations. Error bars represent the sample variation
achieved by bootstrapping (see Section 4.1.2 for a description of bootstrapping). All data but that
in the bottom right graph comes from the experiment that used the OT-1 array of congenic markers
to mark data at a clonal level. The bottom right graph data came from a population level adoptive
transfer experiment that harvested cells at different times. The proportional data shows that the
CD62L+ cells initially have a large proportion of population at days one to two post infection but over
the days they lose share of the population to the faster growing CD62L- cells. The model defines non
naive phenotypes as central memory precursor (TCMp; CD27+CD62L+), effector memory precursor
(TEMp; CD27+CD62L-) and effector cells (TEF; CD27-CD62L-). These data were manually read off
the data points in graph from their supplementary material S26. Proportional data were taken from
Figure 4E.
The summary statistics showing phenotype post infection from the experiments are presented in
Figure 5. From 304 possible differentiation networks two models fit the observed data adequately:
• Naive cells differentiate into TCMp cells (CD62L+CD27+) a few days after activation. TCMp
cells have a chance to differentiate into TEMp cells (CD62L-CD27+) or proliferate. Finally
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TEMp cells have a chance to differentiate into TEF cells (CD62L-CD27-) or proliferate. The
proliferation rate increases for each successive cell-type.
• This model is the same as above, but with the additional small chance of naive cells skipping the
differentiation into TCMp cells (CD62L+CD27+) and directly differentiating into a TEMp cell
(CD62L-CD27+).
See Figure 6 for a qualitative description of the besting fitting network of differentiation model. For
a description of the recreation of this model, including analysis of checks of observations against
predictions, see Section 5.1. Other models were found to be poor fits to the observed data. In
addition, the models that best fitted to day eight summary statistics were found to be a good fit when
compared against the proportional data at a population level taken from days one to eight.
TCMpNaive
TCMp
TCMp
TCMp TEMp
TEMp
TEMp
TEMp TEF
TEF
TEF
TEF
1. After activation the 
naïve cell becomes a 
central memory cell 
(CD62L+CD27+).
2. All central memory cells 
(CD62L+CD27+) slowly proliferate 
with a small chance to become an 
effector memory cell (CD62L–
CD27+).
4. Terminally 
differentiated effector 
cells (CD62L–D27 –) 
proliferate quickly.
1st vs 2nd Model:
Whereas in the first model all naïve cells 
become central memory cells (CD62L+CD27+), 
in the second model there is a 10% chance of 
the naïve cell differentiating directly to an 
effector memory cell (CD62L –CD27+).
3. Effector memory cells (CD62L–
CD27+) proliferate each with a 
very small chance of becoming an 
effector cell (CD62L –CD27 –).
Figure 6: Two best fitting models of CD8+ T cell differentiation proposed in [Buchholz
et al., 2013]. The first model is a linear differentiation model, where naive cells first go through a
memory stage before differentiating into an effector memory cells and finally differentiating into quickly
proliferating effectors. The second model is the same as the first but with a 10% chance for naive cells
to differentiate straight into effector memory cells after activation.
From the data harvested from the day 12 experiment, additional insights were drawn:
• At day 12 post infection most families had well below the mean of 4000 cells (dwarf families)
and a few families generating up to 70,000 descendants (giant families)
• The dwarf families positively correlated with increased expression of CD27+CD62L+ and thus
correlated to a memory phenotype, and the giant families expressed less of those markers, in-
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dicating a correlation to the effector phenotype. Other indicators of phenotype (IL-2, IFN-γ,
Enomes expression and T-bet expression) observed on day 12 post infection confirmed the cor-
relation of dwarf families tending to the memory phenotype and giant families to the effector
phenotype.
• At day 12, out of the 329 single naive donor cells (47 mice, 7 donors each), progeny from 93 cells
(28%) were recovered.
• The variance in family profile showed that CD8+ T cell immune response was only predictable
at a population level. Under ten families cause the population to vary, but 50+ families give a
predictable response.
• The article identified initial events in a family history driving its later profile. The majority of
the population was accounted for by a few families.
3.2.3 [Buchholz et al., 2013] auxiliary experiments and results
A number of additional experiments and results are reported to give additional nuance to conclu-
sions.
Differences of locations: As a check, the authors of [Buchholz et al., 2013] measured total cell
counts in the spleen and observed that it correlated with amalgamated cell counts in other areas of
the body.
Effects of different pathogen: Changing the virus to vaccinia virus–expressing OVA (Vaccinia-
OVA)s, with 5×106 pfu injected, yielded similar results in terms of family size and variance of response.
3.3 Experiment: [Kinjyo et al., 2015]
The authors of [Kinjyo et al., 2015] performed a similar set of OT-1 adoptive transfer experiments
to that of [Buchholz et al., 2013], however [Kinjyo et al., 2015] measured CD8+ T cell behaviour at
a population level rather than a clonal one. This article was novel in its observation of temporal
data on cell proliferation speed. Unlike the [Buchholz et al., 2013] paper, no mathematical model was
employed. Rather a qualitative one is proposed. Later we adapt the mathematical model [Buchholz
et al., 2013] to make it suitable to analyse data acquired from experiments described in the [Kinjyo
et al., 2015] paper (presented in Chapter 5).
3.3.1 [Kinjyo et al., 2015] experimental setup
Experimental Set Up One: Single adoptive transfer. Crossed FUCCI mice, OT-1 mice and
mice with CD45.2 marker, had their cells labelled with CTV and adoptively transferred in Black-6 mice
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(Figure 7). 106 of these donor cells were adoptively transferred into the host mouse (CD45.1). The
host mouse was then infected with 100 pfu of influenza A virus PR8 expressing OVA (PR8-OVA).
At day two, three, four and seven post infection cells were harvested from the MLN, lungs and
spleen and separately analysed. FUCCI expression and CTV fluorescence allowed for information to
be gathered on proliferation rate. To identify correlation of phenotypes, FACS analysis was used to
measure the following on every cell: CD62L, CD44, CD27, CD71, Ly6C, CXCR3, KLRG-1, IL-7Rα
and cell size was also observed.
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Figure 7: Summary diagram of the experimental setup in [Kinjyo et al., 2015]. Adoptive
transfer experiment to observe CD8+ T cell phenotype and division data during the expansion phase.
Experimental Set Up Two: Double adoptive transfer. The authors of [Kinjyo et al., 2015]
wished to see if the CD62Lint could have both CD62L+ and CD62L- progeny. The experiment was
repeated as described for Experiment One up to the point T cells were harvested. In this new ex-
periment harvesting was only performed on day four post infection. The harvested cells were sorted
for CD62Lint (intermediate expression) and for cell trace dye dilution, selecting for cells that were
between the fourth and eighth generation. These sorted cells were transferred into secondary recipi-
ents (CD45.1), who had been infected at the same time as the primary recipients. These were in turn
harvested on day ten after the second transfer and FACS analysis was done on CD62L and FUCCI
expression (Figure 8).
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Figure 8: Summary diagram of the experimental setup in [Kinjyo et al., 2015]. A double
adoptive transfer experiment to observe the phenotype profile of progeny of activated fourth to eighth
generation CD62Lint CD8+ T cells.
Experimental Set Three: In vitro cell time lapse microscopy. Previous work had shown
CD8+ T cell families had heterogeneous differentiation profiles ([Schlub et al., 2009], [Gerlach et al.,
2013], [Buchholz et al., 2013]). To confirm their data were consistent with this, [Kinjyo et al., 2015]
sought to show that there was later heterogeneity in cell cycle time, with strong correlations of lifetime
within families. In an experiment, they activated CD8+ T cells in vitro and allowed them to divide.
Cells from the first, third and eight generations were sorted based on their CTV fluorescence. The cells’
speed of proliferation was determined using both time lapse imaging and FUCCI expression (Figure
9).
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Figure 9: Summary diagram of in vitro time lapse experimental setup in [Kinjyo et al.,
2015]. An experiment to measure distribution and correlation of CD8+ T cell lifetimes within families.
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3.3.2 [Kinjyo et al., 2015] findings
Experiment Set Up One: Single adoptive transfer The article provides data on the percentage
of CD62L+ CD8+ T cells at different times post infection (Figure 10). These data show us an initial
drop in the proportion of CD62L+ expressing cells during the early expansion phase followed by
increase to around 40% of CD62L+ cells by day seven.
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Figure 10: Percentage population of CD8+ cells during the expansion phase that are
CD62L+ as described by [Kinjyo et al., 2015]. Values here were taken from data labels on
graphs [Kinjyo et al., 2015] from their Figure 3a.
The analysis in [Kinjyo et al., 2015] of these data led them to deduce that
“By day four post infection, most of the virus-activated cells showed intermediate level
of CD62L, as a relatively homogeneous population, compared with the distinct CD62L+
and CD62L- subsets present on day seven post infection. [Kinjyo et al., 2015, p.5]”
The distinct nature of the latter two populations is also supported by other differences in their phe-
notypic traits such as size and other markers but CD27, KLRG-1 and IL-7Rα.
[Kinjyo et al., 2015] used FUCCI to give information into cell proliferation speed (see Section 2.4
for information on FUCCI). This combined with CTV information gives understanding into the cells
proliferation rates post infection. The article notes the correlation between speed of proliferation
and effector traits. Gating on CD62L+ showing slower proliferation (mK02+mAG-), whereas CD62L-
correlated to fast proliferation (mK02-mAG+).
Thus [Kinjyo et al., 2015] concludes upon activation the cell becomes a quickly proliferating homo-
geneous population on day four at some point giving rise to a memory like sub-population before day
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seven.
Experimental Set Up Two: Double adoptive transfer. In Experiment One the complete
dilution of cell tracking dye by day seven post infection indicated a large subset of slowly proliferating
cells from the start was unlikely. Memory cells must have either been quickly proliferating at some point
in the expansion phase or differentiated out of the quickly proliferating CD62Lint cells (intermediate
expression). The second experiment showed CD62Lint cells extracted on day four and adoptively
transferred again, gave rise to CD62L+ and CD62L- subsets.
Experiment Set Up Three: In vitro cell time lapse The CD8+ cells from the first and
third generation post infection showed a fast cycle time (averaging 13.4 hours and 14.3 hours). The
eighth generation had an average of 20.5 hours division time, and while most cells were still quickly
proliferating in this generation there existed a slowly proliferating subset. These results were confirmed
by looking at FUCCI expression.
[Kinjyo et al., 2015] investigated correlations in lifetimes of cells from the same family. They found
strong correlations of lifetime between siblings (Spearmans rank coefficient, ρ = 0.91 to 0.98). They
found weaker correlations between mother and daughters (Gen one: ρ = 0.32, gen three: ρ = 0.64, gen
eight: ρ = 0.66), which ties in with previous reports on B cell lifetimes ([Markham et al., 2010],[Hawkins
et al., 2009]). However, if generation eight was partitioned into a quickly proliferating and slowly
proliferating cells, it was found that their progeny’s lifetimes were highly likely to be in the same
partition as their parents. This was not true for generations one and three where slowly proliferating
cells had only a slightly higher correlation in having slow offspring and fast proliferating cells also only
had a slightly increased correlation in having quickly proliferating offspring. Thus the data supported
the hypothesis of a homogeneous population for generation one and three, which eventually split into
two sub-populations, one quickly proliferating and one slowly proliferating, where proliferation speed
is inherited.
From the data described as a result of these experiments, [Kinjyo et al., 2015] determines a quali-
tative model depicted in Figure 11. Upon activation, naive cells differentiate into quickly proliferating
homogeneous population of CD62Lint cells around two-four days post infection. Before day seven the
population became heterogeneous, with cells terminally differentiated into two sub-populations of a
central memory phenotype or effector phenotype.
25
CD62L--
CD62L--
CD62L--
CD62L+
CD62L
+/-
CD62L
+/-
CD62L+
2. Upon activation the cells 
divide and downregulate 
CD62L
3. Population becomes a 
homogenous, quickly 
proliferating and 
expressing intermediate 
levels of CD62L
1. Before infection cells 
are naïve and express 
high amounts of 
CD62L 4. The intermediate cells terminally 
differentiate either into slowly 
proliferating memory phenotype of 
quickly proliferating effector 
phenotype.
CD62L+
CD62L
+/-
CD62L
+/-
CD62L
+/-
CD62L
+/-
CD62L
+/-
CD62L
+/-
CD62L
+/- CD62L
+/-
CD62L--
CD62L--
CD62L--
CD62L-- CD62L--
CD62L-- CD62L--CD62L--
CD62L+
CD62L+CD62L+
TIME
CD62L+
C
D
6
2
L
 
Day 2-3Day 0 Day 4 Day 7
Figure 11: Qualitative model proposed in [Kinjyo et al., 2015]. In this model, after activation,
cells become a homogeneous population of quickly proliferating CD62Lint effector like cells by day four.
This splits into two sub-populations similar to memory and effector phenotypes by day seven.
3.3.3 [Kinjyo et al., 2015] auxiliary experiments and results
Experiments showing that FUCCI expression is a good indicator of cell proliferation
speed: [Kinjyo et al., 2015] does a number of experiments to confirm properties of FUCCI. For
example, on day seven post infection mice were injected with BrdU (Bromodeoxyuridine, a substance
cells incorporate into their DNA during DNA synthesis) and spleens where harvested three, five or
seven hours later. While some mK02+, mAG- cells incorporated BrdU at every time point, this
occurred at a significantly lower rate than its mK02-,
Differences in location: The split of the data between location (spleen, lung and MLN) showed
many differences T cell population dynamics at different parts of the body. By day four post infection,
FUCCI expression indicated cells in the MLN reproduced the quickest, followed by those the lungs
and finally the slowest proliferating cells were in the spleen. This was supported by the generational
data from CTV. However one must be mindful of the effects of an unknown amount of cell migration
might have on these results. Also, similar to other reports ([Kedzierska et al., 2007]), a population of
cells with a central memory phenotype (CD44+CD62L+) appeared in the spleen and MLN, but not
in the lungs.
Cell life time correlation and environmental factors: In a similar setup to that of Experiment
Three, [Kinjyo et al., 2015] found no correlation between unrelated cells that shared a well, supporting
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the hypothesis that inheritance of lifetime is driven by internal mechanisms rather than environmental
ones.
Cell size: Cell size was observed in many of these experiments and it was found that larger cells
both divided faster and had lower expressions of CD62L than their smaller counterparts. This lead to
a conclusion that size could be correlated with cell-type.
3.4 Experiment: [Badovinac et al., 2007]
One of the differences in setup between the experiments described in [Buchholz et al., 2013] and
[Kinjyo et al., 2015] was the number of T cells adoptively transferred (1 × 102 − 1 × 104 and 1 × 106
respectively). The paper [Badovinac et al., 2007] reports data on the effects of transferring different
numbers of cells in OT-1 adoptive transfer experiments and allows us to estimate the effect of this
difference on T cell behaviour. This paper also contains a similar experimental setup to [Kinjyo et al.,
2015] and [Buchholz et al., 2013] (an adoptive transfer experiment where cells are harvested different
times post infection at a cohort level) and reports similar population level data. Specifically of interest
to us is the proportion of CD62L+ cells at different times post infection.
3.4.1 [Badovinac et al., 2007] experimental setup
Patho
gen
Naive
Naive
Naive Flow 
Cytometer
?
?
?
?
1. Donor mouse crossbred so as to 
express CD90+. 
2. Adoptive transfer of different 
numbers (5×101, 5×102, 5×103, 5×104 , 
5×105) of purified naïve T cells from 
donor mice to host mouse. 
3-74  days post 
infection
3. Host mouse is infected with 
OVA expressing pathogen 
triggering the immune 
response. 
4. At a fixed time after infection cells 
are harvested from the host mouse 
from the blood from small tail snips.
5.FACs analysis. For observed T cells, 
the CD90 congenic markers indicate 
donor progeny from the hosts progeny. 
CD62L and CD127 markers observed. 
This is gathered at a population level.
Analysis
CD90-CD90-
CD90+
Figure 12: Summary diagram of the experimental setup in [Badovinac et al., 2007].
Adoptive transfer experiment to observe CD8+ T cell phenotype and division data during the expansion
phase when varying the number of cells adoptively transferred.
The authors of [Badovinac et al., 2007] describe an adoptive transfer experiment using different
numbers of transferred cells: 5 × 101, 5 × 102, 5 × 103, 5 × 104 and 5 × 105. The experiment was
repeated with four donor mice per case. Naive cells from CD90+ OT-1 mice were transferred into host
CD90- black-6 mice, and these were infected with 7 × 106 cfu LM-Ova one day after T cell transfer.
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Data were collected from blood taken from tail snips done on days three, four, five, six, seven, 10, 13,
26, 40 and 74 post infection. FACS analysis was used to determine CD62L, CD127 and CD90 (Thy-1)
expression of harvested cells. CD90 was used to determine which lymphocytes were the progeny of the
OT-1 adoptively transferred cells.
3.4.2 [Badovinac et al., 2007] findings
Experiments with a high number of adoptively transferred cells had an earlier peak and shorter
expansion phase. For the experiment transferring 5 × 105 cells the peak immune response occurred
at day five and while experiments transferring low number of cells (less than 500) had a peak at day
seven. When transferring 5 × 105 cells, family size increased only 40 - 400 fold on average up to the
peak, compared to the 400,000 fold increase on average for the experiment transferring 5 × 101 cells.
We use these results later in Section 5.3.3 to estimate the expansion phase length and average family
size at peak immune response for the experiments described in [Buchholz et al., 2013] and [Kinjyo
et al., 2015]. Results from [Badovinac et al., 2007] showed proportions of cells expressing high levels
of CD127 or CD62L was larger during the memory phase of the immune response for experiments
transferring more cells. In all cases, the proportion of CD62L+ cells initially decrease after activation
and this proportion eventually increases later in the immune response, but higher transfer number
cause this turnaround earlier, as seen in Figure 13. [Badovinac et al., 2007] estimated that excess
of 350 cells adoptively transferred will alter the expansion, timescales and phenotype of an immune
response.
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Figure 13: Percentage population of CD8+ T cells during the first eight days that are
CD62L+ for different numbers of transferred cells. Values here were taken from graphs in
[Badovinac et al., 2007] Figure 4.b
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3.4.3 [Badovinac et al., 2007] auxiliary experiments and results
[Badovinac et al., 2007] also investigated how high adoptive transfer number effected results when
using a P14 experimental model as opposed to an OT-1 model. P14 mice have T cells specific to
the antigen LCMV GP33-41. The P14 TCRs bind to LCMV GP33-41 with less affinity than the
OT-1 TCRs binds to SIINFEKL. The results from the experiment described in [Badovinac et al., 2007]
showed the P14 experiment had a higher threshold for the number of adoptive transferred cells that
would significantly alter the endogenous immune response (estimates of a 350 cell threshold for OT-1
compared to a 6000 threshold for P14).
The authors of [Badovinac et al., 2007] showed that changing the pathogens carrying the antigen,
such as virulent LM-ova or vaccine virus expressing Ova257 did not have a significant effect on the
results previously listed for the OT-1 model. This was also the case when using lower doses of the virus.
This further supported that the differences in the pathogens used between experiments described in
[Buchholz et al., 2013] and [Kinjyo et al., 2015] should have minimal impact.
[Badovinac et al., 2007] reported an experiment that counted the number of OT-1 cells and endoge-
nous T cells in the spleen post infection with different sizes of OT-1 adoptive transfer. This showed
that while higher numbers of transferred cells did increase the total count of OT-1 T cells in the spleen
at day seven post infection, the increase was not proportional, showing that either cells had died in
significant numbers or had not divided as many times. When measuring endogenous T cells at day
seven, total counts were lower for very high transfers compared total counts for low transfers, showing
high transfers reduce the endogenous immune response size.
3.5 Experiment: [Schlub et al., 2010]
The [Schlub et al., 2010] paper reports data on proportions of CD8+ T cells in the blood that are
CD62L+ at different days post infection from an OT-1 adoptive transfer experiment. They repeated
this for different numbers of adoptively transferred cells. The purpose of their experiments was to
determine the rate at which CD62L+ cells become CD62L- during the expansion phase. As papers
such as [Badovinac et al., 2007] had shown, adoptively transferring very large quantities of cells with
pathogen specificity can greatly reduce the number of divisions T cells undergo during the expansion
phase. By varying the number of cells transferred, and thus the average number of cell divisions, the
authors of [Schlub et al., 2010] looked to find a link between division number and CD62L+ expression.
We considered this paper in detail because:
1. It contains a similar experimental setup to one of the experiments in [Kinjyo et al., 2015] and
[Buchholz et al., 2013] (an adoptive transfer experiment at cohort level) and reports the pro-
portion of CD62L+ at different times post infection. We later fit an adapted expansion phase
models to these data in Section 5.3.5.
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2. The additional data on the effects of high numbers of adoptively transferred cells allows us to
estimate the impact of this on the [Kinjyo et al., 2015] reported results. We estimate the impact
of high transfer numbers in Section 5.3.3.
3. [Schlub et al., 2010] suggests a methodology for estimating the average number of relative di-
visions cells go through when varying adoptive transfer sizes. In Section 5.3.3 we borrow and
extend this method to estimate average family size and we use this for the adapted mathematical
model we later employ.
3.5.1 [Schlub et al., 2010] experimental setup
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Figure 14: Summary diagram of the experimental setup in [Schlub et al., 2010]. Adoptive
transfer experiment to observe CD8+ T cell phenotype and division data during the expansion phase
when varying the number of cells adoptively transferred.
The paper [Schlub et al., 2010] describes an adoptive transfer experiment where naive cells from
a donor CD90- OT-1 mouse were transferred into CD90+ black-6 mice. The host mice were infected
with 8× 106 LM-Ova cfu one day after transfer. Mice were bled from tail snips at days four, five, six,
seven, eight, 10, 13, 20, 35 and 53 post infection. FACS was used to determine CD62L, CD27 and
CD90 (Thy-1) expression of harvested cells (the last of these to determine which cells are the progeny
of the OT-1 adoptively transferred cells). This experiment was repeated using different numbers of
transferred cells: 3.2 × 103, 1.6 × 104, 8 × 104 and 4 × 105 and repeated with four donor mice per
adoptive transfer experiment.
A second similar experiment was performed where cells were harvested from spleen, but only with
3.2 × 103 or 4 × 105 cells adoptively transferred and observations were taken only on fewer days
and CD62L expression was not reported. However counts of lymphocytes in the spleen (rather than
proportions), split by OT-1 and non OT-1 were reported.
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3.5.2 [Schlub et al., 2010] findings
Confirming [Badovinac et al., 2007], these data showed that experiments with high numbers of cells
adoptively transferred showed an increase in the proportion of CD62L+ cells before day eight whereas
low number of adoptively transferred cells are seen to continually decrease (Figure 15).
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Figure 15: % population of CD8+ cells during the expansion phase that are CD62L+ as
described by [Schlub et al., 2010]. Values taken from [Schlub et al., 2010] Figure 1.
While the key objectives of the [Schlub et al., 2010] paper, using a mathematical model to deter-
mine the rate CD62L+ cells become CD62L- is relevant to us, a number of core differences in their
assumptions will mean we only touch on their mathematical method briefly. The most significant
assumptions [Schlub et al., 2010] make, which we do not, is that CD62L+ and CD62L- cells divide at
approximately the same rate, that naive cells initially divide into CD62L+ cells then and eventually
differentiate into CD62L- cells.
Using this experimental data, [Schlub et al., 2010] employs three methodologies to calculate the
relative number of divisions a family goes through and correlates this to the rate at which the propor-
tion of CD62L+ cells decreases during the expansion phase. We describe this method more thoroughly
in Appendix A. The counts of T cells in the spleen indicated that the total numbers of lymphocytes
(endogenous plus transferred) were similar at peak for both high and low transfers. Fitting an ex-
ponential line between the calculated difference in number of divisions and the expression of CD62L
give a good fit (r=-0.91, p <0.0001, Spearman’s tied-rank correlation) and it is interpreted that each
CD62L+ cell had a 21.2% chance to differentiate to a CD62L- cell upon division.
The data from their experiments gave further evidence of the effects of adoptive transfer of large
numbers of OT-1 cells on the immune response. Under the assumptions of the model, in an experiment
with 4× 105 cells adoptively transferred a family will go through approximately 5-6 less divisions than
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an experiment transferring 3.2 × 103 cells. The peak of adoptive transfer, was seen to be earlier for
higher adoptive transfer numbers, thus while 3.2 × 103 had peak immune response on day six, the
adoptive transfer of 4× 105 cells peaked at day four or earlier. For the adoptive transfer of 3.2× 103
cells, at peak immune response, approximately 25% of OT-1 cells were CD62L+, whereas for the
experiment that transferred 4× 105 cells, this was around 60% (Figure 15).
3.5.3 [Schlub et al., 2010] auxiliary experiments and results
[Schlub et al., 2010] sought to determine if there was a similar link with division rate and CD127
expression as they did with CD62L, where CD127 is used to discriminate between effector memory
and effector cells. However the exponential fit described in method was not as good as in the CD62L
case and there are examples of CD127 actually increasing during periods of the expansion phase.
[Schlub et al., 2010] also noted that less than 0.1% of naive cells were unrecruited at the peak of expan-
sion phase, thus ruling out the possibility of unrecruited cells greatly affecting the CD62L+ proportion.
3.6 Comparing experimental systems and results
3.6.1 Comparing all experimental systems: [Badovinac et al., 2007], [Schlub et al., 2010],
[Buchholz et al., 2013] and [Kinjyo et al., 2015]
Experiments described in these papers had many similarities that allow for their comparison. All
papers describe adoptive transfer of naive CD8+ T cells from donor OT-1 mice to host black-6 mice,
and at varying times post infection FACS analysis was done on harvested cells. All experiments used
transgenic markers to distinguish between host and donor cells (CD45 or CD90) and all used pathogens
expressing OVA to trigger the immune response.
There were also significant differences and these are compared in Table 4. Only [Buchholz et al.,
2013] described an adoptive transfer experiment that observed the immune response at a clonal level,
at one time point, day eight post infection. That clonal data were what the mathematical model
described in [Buchholz et al., 2013] was fitted to. All the papers (along with another experiment
from [Buchholz et al., 2013]), described experiments reporting data at cohort level, and these data are
observed at multiple time points. This means that if we are to compare papers we have to do so at
a population level rather than a clonal one. We see in Section 4.3 that the model [Buchholz et al.,
2013] employed also used CD27 expression data and sample error data, some or all of which was not
reported in the other experiments.
As mentioned, one of the significant differences between [Buchholz et al., 2013] and [Kinjyo et al.,
2015] was the number of cells adoptively transferred, shown in Table 4. [Kinjyo et al., 2015] and
[Buchholz et al., 2013] both gathered their data from the spleen for their population level experiments.
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[Badovinac et al., 2007] and [Schlub et al., 2010] report data taken from blood tail snips. Blood data
were taken from the same mice at different times whereas spleen measurements require mice to be
sacrificed at each time point. Both [Badovinac et al., 2007] and [Schlub et al., 2010] report some
spleen data from other experiment but this is too limited for our modelling purposes. The papers
[Buchholz et al., 2013] and [Schlub et al., 2010] did experiments to check that samples of T cells taken
from specific parts of the body are representative of the whole, however [Kinjyo et al., 2015] reported
considerable differences in T cell division speed and generational data between locations. Therefore
difference in location between papers must always be kept in mind when comparing results.
The papers [Buchholz et al., 2013] and [Kinjyo et al., 2015] focused on finding the order of differen-
tiation within the expansion phase. [Kinjyo et al., 2015] relies on FUCCI expression indicating speed
of cell differentiation and CD62L as the primary indicator of cell-type and then used correlations of
other characteristics such as cell size to further support their classification. [Buchholz et al., 2013]
used CD62L and CD27 as the primary indicators of cell-type with additional factors such as T-bet to
support their classification.
[Kinjyo et al., 2015] used the pathogen PR8-Ova to induce an immune response, whereas the other
experiments used LM-Ova. Different quantities of pathogens were used between experiments as seen
in Table 4. However, both [Buchholz et al., 2013] and [Badovinac et al., 2007] gave evidence that
the different pathogen on the OT-1 model had little effect on results. The gating strategies used to
phenotypically define cell-types were different in each paper (Table 4) and this should be kept in mind
when comparing cell surface marker expression data between experiments.
These factors will need to be considered, as differing conclusions could have an experimental expla-
nation, such as the treatment of location or phenotype profiling, rather than analytical ones.
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Setup [Badovinac
et al., 2007]
[Schlub et al.,
2010]
[Buchholz
et al., 2013]
clonal experi-
ment
[Buchholz
et al., 2013]
cohort experi-
ment
[Kinjyo et al.,
2015]
Factors in com-
mon
Adoptive transfer experiment where OT-1 cells are transferred to black-6 (C57BL/6) mice. Cells
are harvested at different times post infection and the proportion of CD62L+ is recorded.
Naive cells trans-
ferred
5× 101
5× 102
5× 103
5× 104
5× 105
3.2× 103
1.6× 104
8× 104
4× 105
107 1× 102
(6,8 days p.i.)
1× 104
(1-4 days p.i.)
1× 106
Location cells
harvested from
(as reported)
blood blood lungs + Lymph
nodes (multiple)
+ spleen (split
not reported)
spleen spleen, MLN
(split reported)
Times post in-
fection cells har-
vested (days)
3, 4, 5, 6, 7, 10,
13, 26, 40, 74
(earlier days
missing for
larger transfers)
4, 5, 6, 7, 8, 10,
13, 20, 35, 53
8 1, 2, 3, 4, 6, 8 0, 2, 3, 4, 7
Pathogen appli-
cation
LM-Ova bacteria
7× 106
LM-Ova bacteria
8× 106 cfu
LM-Ova bacteria
5× 103 cfu*
LM-Ova bacteria
5× 103 cfu*
PR8-Ova virus
1× 102 pfu
Host identifiers CD90.1.1 CD90.1.2* CD90.2.2CD45.2.2 Data not re-
ported
CD45.1
Donor identifiers CD90.1.2 CD90.1.1 CD90.1.1CD45.1.1
CD90.1.2CD45.1.1
CD90.2.2CD45.1.1
CD90.1.1CD45.1.2
CD90.1.2CD45.1.2
CD90.2.2CD45.1.2
CD90.1.1CD45.2.2
CD90.1.2CD45.2.2
Data not re-
ported
CD45.2
Number of host
mice per experi-
ment
4 4 47 47* 9
Effector memory
vs effector identi-
fier
CD127 CD127 CD27 CD27 Data not re-
ported
CD62L gating
threshold (ap-
proximate, read
from diagrams)
50* 20 100-150 100-150 2000
Clonal/cohort
level data
Cohort Cohort Clonal Cohort Cohort
Sample error
data (or equiva-
lent)
No Yes Yes Yes No
Table 4: Summary comparison of experimental setups and data reported. As papers include
multiple experiments and this table only refers to that which returns proportion of CD62L cells at
different times. The * indicates some inference from the reader, usually from a description of another
experiment in the paper that is assumed to be carried over between experiments.
3.6.2 Comparing results: [Badovinac et al., 2007], [Schlub et al., 2010], [Buchholz et al.,
2013] and [Kinjyo et al., 2015]
All papers have experiments that provide data on the proportion of CD62L+ cells over time up to
day eight post infection. This is compared in Figure 16.
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Figure 16: Proportion of CD62L+ OT-1 cells after infection in adoptive transfer experi-
ments reported in papers [Buchholz et al., 2013], [Kinjyo et al., 2015], [Badovinac et al.,
2007] and [Schlub et al., 2010]. Colours represent ranking of number of cells adoptively trans-
ferred: high number indicated by a red hue and low numbers by a blue hue. All experiments showed
an early decrease in the proportion of CD62L+ cells. Experiments with higher numbers of cells adop-
tively transferred tended to show an increase in the proportion of CD62L+ cells earlier in the immune
response. All experiments used different gating thresholds. Data taken from: [Badovinac et al., 2007]
graph 4b [Schlub et al., 2010] graph 1d, [Buchholz et al., 2013] graph in the supplementary material
S26, [Kinjyo et al., 2015] data labels in Figure 3a. Some data sets did a prior infection observation
([Schlub et al., 2010] and [Kinjyo et al., 2015]) and this point was not fitted to.
All data up to day two showed an initial large CD62L+ population. However, [Kinjyo et al., 2015]
associates this with cells still being naive whereas [Buchholz et al., 2013] associates this with an early
memory population. All graphs show a decrease in this initial CD62L+ population, which both [Kinjyo
et al., 2015] and [Buchholz et al., 2013] put down to the effector pool increasing in size (TEMp and
TEFs in [Buchholz et al., 2013]’s model). However, [Kinjyo et al., 2015] reported an increase in the
percentage of CD62L+ towards the day seven, similar to that seen in other papers, which also had
high numbers of adoptively transferred cells ([Bachmann et al., 2005]), and this was explained by cells
differentiating into memory cells, whereas [Buchholz et al., 2013] continues to show a decrease.
As [Badovinac et al., 2007] and [Schlub et al., 2010] have shown, large adoptive transfers can lead to
and earlier increase in CD62L+ such as that seen in [Kinjyo et al., 2015]. This leads to the hypothesis
that some of data reported in [Kinjyo et al., 2015] may not be in the expansion phase, despite the fact
the expansion phase traditionally considered to extend to day seven-eight post infection. Noticeably,
while we have seen that high adoptive transfer usually causes high levels of CD62L+, expression
reported in [Kinjyo et al., 2015] dips below that of [Buchholz et al., 2013] on day four, though differing
gating strategies could perhaps explain this. Also, mesenteric lymph node (MLN) data from [Kinjyo
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et al., 2015] exhibited an increase in proportion of CD62L+ cells even earlier, from day two to three
(Figure 10), a slightly different pattern from the spleen, which might still indicate some early creation
of memory, but the absence of MLN CD62L+ data from the papers we compare makes it is difficult
to evaluate this further.
Another area where both [Kinjyo et al., 2015] and [Buchholz et al., 2013] have comparable data is
the generation profile of cells at days three and four post infection as seen in Figure 17.
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Figure 17: Graphs showing OT-1 cells generation profile at a population level in [Buchholz
et al., 2013] and [Kinjyo et al., 2015] experiments. [Buchholz et al., 2013] has almost entirely
diluted dye by day four. In addition to the data shown, all dye was diluted in [Kinjyo et al., 2015] at
all locations by day seven (no data from day seven was reported [Buchholz et al., 2013]). This could
be considered evidence against a slowly proliferating subset in the population. The overall slower
proliferation of [Kinjyo et al., 2015] compared to [Buchholz et al., 2013] could be due to the size of
adoptive transfer which has been shown to reduce the number of divisions cells go through. Values
for [Kinjyo et al., 2015] were manually extracted from CTV flow plots, their Figure 1.b and [Buchholz
et al., 2013] data were taken from graph points in their supplementary material S22.
The T cells [Buchholz et al., 2013] reported, taken from the spleen, show a faster rate of proliferation
than those reported in [Kinjyo et al., 2015] taken from any location. In addition, [Kinjyo et al., 2015]
also observed complete cell dye dilution at all locations on day seven, a result which [Buchholz et al.,
2013] saw by day four (using CFSE vs CTV). [Kinjyo et al., 2015] uses this fact to conclude that
cells cannot be of a slowly proliferating lineage throughout the expansion phase, a requirement for the
[Buchholz et al., 2013] model. One possible explanation of the faster proliferation of [Kinjyo et al.,
2015]’s data compared to [Buchholz et al., 2013] may be high adoptive transfer size, as we have seen
this leads to smaller family size.
The complete CTV dilution seen in [Kinjyo et al., 2015] on day seven suggests the immune response
is still in the expansion phase for a significant time after day four, despite evidence from [Badovinac
et al., 2007] and [Schlub et al., 2010] that the expansion phase for such a high adoptive transfer should
end around this time. Thus, while day seven CD6L+ profile in [Kinjyo et al., 2015] matched that
of a high adoptive transfer, the generational data on day seven was seemingly contradictory to it.
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As [Schlub et al., 2010] and [Badovinac et al., 2007] do not reported generational data it is hard to
compare, but one possible explanation is that cell death could be influencing the appearance of the
generational profile of [Kinjyo et al., 2015] by day seven.
3.6.3 Comparing models: [Buchholz et al., 2013] and [Kinjyo et al., 2015]
Due to their novel experimental set-up [Buchholz et al., 2013] is able to propose how cells expand and
differentiate at a clonal level, which can be translated into a population level. The authors of [Kinjyo
et al., 2015] propose a model for cell differentiation behaviour only at a population level with some
unknowns about the clonal level, most notably, the heterogeneous population at day seven described
by [Kinjyo et al., 2015] could be made up of homogeneous or heterogeneous individual families.
As [Buchholz et al., 2013] used mathematical model fitting, their model is also quantitative and fully
descriptive, for example giving rates of division, whereas [Kinjyo et al., 2015] is qualitative. However,
the [Buchholz et al., 2013] relies on strict assumptions, such as independence of cell behaviours (these
model assumptions are reviewed in Chapter 6).
Both models propose very different differentiation dynamics for the expansion phase. Most notably,
while both require a down regulation of CD62L during initial stages of the expansion phase, [Buchholz
et al., 2013]’s model necessitates this trend continues whereas [Kinjyo et al., 2015] allows for it to
increase near day seven. Both these models tie with their respective observed proportions of CD62L+
cells against time.
In terms of population growth dynamics, both models are different, with [Kinjyo et al., 2015]
suggesting that all cells and families enter a stage of fast proliferation after activation, with a subgroup
slowing down to a memory cell-type by day seven. [Buchholz et al., 2013] would suggest all cells having
to go through slower proliferation during the early expansion phase, and some cells would speed up
division only later once they have proliferated and also suggests that memory cells will have never
entered a period of fast average proliferation.
Using an adapted version of [Buchholz et al., 2013]’s method, we compare the models fitted to
data in these experiments, looking specifically at CD62L. We do this in Section 5.2.3. We also review
assumptions and alternative models in Chapter 6.
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4 Mathematical models used to interrogate the CD8+ T cell
expansion phase
This chapter describes pre-existing mathematical and statistical results that are used to help model
and explain the CD8+ T cell expansion phase. Firstly, we review some of the tools of mathematical
modelling. Secondly, we describe the family of models that the authors of [Buchholz et al., 2013]
selected from to find best fit models, known as multi–type Bellman-Harris processes. Finally, we shall
describe how these tools are used by [Buchholz et al., 2013] specifically. We go on later in the thesis
to adapt these tools to fit models to other data such as that of [Kinjyo et al., 2015].
4.1 Using summary statistics to find the best fitting mathematical models
4.1.1 Motivation
While the mechanics that control the immune system are not fully understood, their results are
partly visible in experiments such as those described in Chapter 3. If we want to approximate these
dynamics with a mathematical model, we inform the model design by basing the assumptions on
deductions from biological observations; for example, the fact that cells always divide into no more
than two cells. The way T cell families divide and differentiate during the immune response has
been observed to be highly heterogeneous ([Gerlach et al., 2013], [Buchholz et al., 2013]); therefore, a
deterministic model at a clonal level would be inappropriate. Some elements of the expansion phase
can be modelled as if taking samples from a random variables whose distributions are unknown, but
are informed from biological experiments.
Once a list of reasonable assumptions for a mathematical model has been selected, this may not
have narrowed down the possibilities to one model or a given set of parameters. In order to rank those
models that remain, we seek to compare the observed statistics from experiments with the statistics
calculated from the mathematical models. We may also want to penalise more complex models based
on Occam’s razor.
4.1.2 Ranking models
Suppose we have m replicates of an experiment, and each experiment takes n real valued measure-
ments, then we denote the total mn observations as a matrix Om×n ∈ Rm×n and call this the dataset.
We also define oi,j ∈ R as the jth measurement in replicate i. We denote the n measurements seen in
replicate i as a vector ~oi = (oi,1, ..., oi,n).
In the case of [Buchholz et al., 2013], there were 47 transferred T cell families recovered (m = 47)
from an adoptive transfer experiment on day eight post infection. For each of these experiments, the
38
cells count of three phenotypes was recorded (CD62L+CD27+, CD62L-CD27+ and CD62L-CD27-,
n = 3). Each clonal family from within the same mouse is assumed to be an independent replicate of
an experiment.
Suppose we have a function ~s : Rm×n → Rk defined as ~s(Am×n) = (s1(Am×n), ..., sk(Am×n)) where
si : Rm×n → R for i = 1, ..., k. Thus, each of the k functions si(Om×n) returns a statistic of the data
set Om×n and ~s(Om×n) is a vector of statistics which we call the observed statistics. For brevity
we shall denote the vector of observed statistics ~s(Om×n) as xˆ = (xˆ1, ...xˆk).
In the case of [Buchholz et al., 2013] the authors calculated nine summary statistics (k = 9) on
their data set O47×3 ∈ R47×3. This was made up of three means
xˆj = sj(O47×3) =
1
47
47∑
i=1
oi,j for j = 1, 2, 3,
three coefficients of variation
xˆj+3 = sj+3(O47×3) =
√
1
47
∑47
i=1(oi,j)
2 − xˆ2j
xˆj
for j = 1, 2, 3
and three correlation coefficients
xˆ7 = s7(O47×3) =
1
47
∑47
i=1 oi,1oi,2 − xˆ1xˆ2
xˆ4xˆ5xˆ1xˆ2
xˆ8 = s8(O47×3) =
1
47
∑47
i=1 oi,1oi,3 − xˆ1xˆ3
xˆ4xˆ6xˆ1xˆ3
xˆ9 = s9(O47×3) =
1
47
∑47
i=1 oi,2oi,3 − xˆ2xˆ3
xˆ5xˆ6xˆ2xˆ3
.
Let us also suppose we have a probabilistic model that we think approximates the experiment and we
calculate the expected value of each of the k summary statistics according this model. We denote each
calculated statistic from the model as xi ∈ R for (1 ≤ i ≤ n), with ~x = (xi, ..., xk), and call this vector
the model statistics. The authors of [Buchholz et al., 2013] used a family of stochastic processes
known as multi-type Bellman-Harris processes to model the data, which we detail later. From these,
they calculated model statistics.
We wish to define a function that measures the distance between xˆ and x to see how well model
statistics explain observed statistics. This is done with an objective function denoted by f(xˆ, x),
f : R2k → R.
There are many candidates for what the objective function could be and selection should be informed
by what we think is important in terms of fit, for example, non–negativity and the function should be
zero if and only if x = xˆ. One option is the mean squared error (MSE) ([Bertsekas and Tsitsiklis,
2002, Ch. 8.3]) defined by
MSE(xˆ, ~x) =
1
n
k∑
i=1
(xˆi − xi)2. (1)
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The squaring of the differences means larger errors are penalised more harshly. There are some cases
when this is an inappropriate choice of objective function, such as if statistics have a wide range of
magnitudes and variances. This would mean statistics of larger magnitude or variance will have a
disproportional effect on the MSE than smaller ones.
To account for this, we may wish to use a similar function that adjusts for the standard error of
the mean (SEM) of the statistics and we denote the sample variance as σˆ2i ∈ R of each summary
statistic xˆi. The sample variance of the observed statistics may be unknown a priori, but can be ap-
proximated by bootstrapping ([Press et al., 1992, Ch. 15.6]). Bootstrapping allows us to estimate the
underlying distribution the dataset is selected from by creating new datasets O′m×n ∈ Rm×n by random
sampling with replacement from the original data set. Experiments must be i.i.d. (independent and
identically distributed) in order for this technique to be appropriate. To allow us to randomly sample
from these data we create a series of i.i.d. discrete random variables that take uniform distributions
over integers between one and the number of experiments (m) and we denote these random variables
Yi, with i = 1, 2, 3, .... Then ~oY (i) is a random sample of one experiment from Om×n. For j = 1, 2, 3, ...
we define a new dataset Ojm×n ∈ Rm×n as a dataset created by randomly sampling from the original
dataset, Ojm×n = (~oY (mj+1), ..., ~oY (mj+m)). We want a large number of such samples which we denote
l. Then the value of σ2i is approximated by
σˆ2i ≈
1
l
l∑
j=1
si(O
j
m×n)
2 − 1
l2
(
l∑
j=1
si(O
j
m×n))
2.
The bootstrapping method is used in [Buchholz et al., 2013] to approximate the value of the sample
variance.
A similar measure to the mean squared error is least squares or standard χ2 ([Press et al., 1992,
Ch. 15.1]) which is calculated as
χ(xˆ, ~x) =
k∑
i=1
(xˆi − xi)2
σˆ2i
. (2)
In this case different magnitudes of standard deviation are adjusted for. However, this does not adjust
for any covariance between the summary statistics. The statistics used to fit in [Buchholz et al., 2013]
had sample variances of differing magnitudes, hence the authors used χ2 minimization (2) to measure
the distance between their observed statistics and their model statistics.
Let us suppose we have a probabilistic model that we suspect captures the underling dynamics that
created the data set and this model is parametrised by q parameters (~θ ∈ Rq) and the set of all possible
parameters is Θ ⊂ Rq. For each ~θ, we denote this model’s respective vector of calculated statistics
as ~x(~θ) ∈ Rk. For a given objective function f and a given set of observed statistics Om×n, we can
use an objective function such as MSE (1) or χ2 (2) to identify the parameters of the model that give
an infimum distance between the observed statistics and the model statistics. The values of ~θ, should
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they exist, that return this minimum value objective function, are denoted as
{~θ∗} = arg inf
~θ∈~Θ
f(xˆ, ~x(~θ)). (3)
and this set we call the best fit parameterisation(s). Thus, we have a method of choosing a ~θ∗ ∈ Θ
that best approximates the data according to an objective function.
Unless the function being optimised is convex, solving optimisation problems can be a challenge
and this is a rich field of research in itself. There are many computer algorithms designed to find
a minimum value of a function. These minimising programmes require equivalents of the following
inputs: the objective function redefined f(xˆ, ~x(~θ)) : Rq → R where ~θ is now the variable and xˆ is
fixed, a starting point ~θ ∈ ~Θ, bounds for the variable defining ~Θ ⊂ Rq (optional), and a selected
algorithm, for example the authors of [Buchholz et al., 2013] used a trust-region-reflective algorithm
(Conn et al. [1987]). There is no guarantee that this function will return the global minimum and not
a local one. This is mitigated by the use of multiple start points for ~θ0 ([Buchholz et al., 2013] used
300 different start points) or using a range of algorithms and choosing the minimum of these. Thus, we
have a method for acquiring the best fitting parameters as described in (3) for a given model, objective
function and observations.
Supposing we have r different mathematical models labelled i (with i ∈ {1, ..., r}) whose parameters
take values in their respective spaces ~Θi that may have a different number of dimensions q. One method
to determine which model best describes the data is to find the minimum of the objective function
f(xˆ, ~x(θ)) over ~θ ∈ ~Θi for each model and then finding the lowest value of the objective function across
all r models. However, it may be the case that we wish to penalize models for higher complexity as
this carries the risk of over fitting. It may also be that some sets of models may be a subset of one
another. This is known as one set of models being nested in another.
One possible method could be to rank the models by using the χ2 minimization value divided by
the degrees of freedom (d.o.f.) ([Press et al., 1992, Ch. 15.1]). A degree of freedom is the number
of independent scores (observations that make up this estimate), m, minus the number of parameters
q. The values of (2) for the different models are ranked only after being divided by their respective
d.o.f.
An alternative method would be to use Akaike information criterion (AIC) ([Akaike, 1974]).
For each model, where q is the number of model parameters that are fitted and L is the maximum
value of the likelihood function, i.e. for a given model i, L(~x|~θ) is the maximized value of P (~x|~θ) for
all ~θ ∈ ~Θ, the AIC value is given as
AIC = 2q − 2ln(L(~x|~θ)). (4)
There is also a corrected Akaike information criterion (AICc) ([Akaike, 1974]) that takes into
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account the size of a finite sample (m) and this is calculated as
AICc = 2q − 2ln(L) + 2q(q + 1)
m− q − 1 . (5)
Models that return lower values from χ2 minimization corrected by the degrees of freedom or AICc
indicate a better fit and thus models can be ranked. It is important to note that this is a relative method
of comparing models rather than an absolute one and does not compare against a null hypothesis.
The authors of [Buchholz et al., 2013] used both AICc on the likelihood function and χ2 value
corrected by the degrees of freedom to rank suggested models of the CD8+ T cell expansion phase.
We recreate this and adapt it to new data in Chapter 5.
4.2 Bellman-Harris processes
4.2.1 Description of a Bellman-Harris process
A Bellman-Harris process is a probabilistic model describing how populations of objects reproduce,
go extinct or expand over time. Applications include populations of animals reproducing, particles in
a nuclear cascade, names in a family tree or cells dividing.
We first give a high level informal description of a Bellman-Harris process and then define it precisely
and mathematically. Let us say we have one object alive at time zero, and we assign this object a
random lifetime. At the end of the object’s lifetime, it has a random number of children, which could
be any integer including zero. These new objects are then also assigned random lifetimes and they also
have a random number of children upon their death. This process continues, giving rise to a family
tree, otherwise known as an age dependent branching process. A core assumption of the Bellman-
Harris process is that the lifetime of each of the objects are i.i.d. Throughout this section we say these
lifetime random variables are identical to a random variable J . Also, the distribution of the number of
offspring that each object has upon death is i.i.d.. We shall call a random variable identical to these
offspring random variables as H. In addition, all the distributions of offspring are independent from
the lifetime distributions. The term Bellman-Harris process also includes processes with more than
one object alive at time zero, but we only look at cases starting with one ancestor object and these
results can be easily expanded to cases starting from multiple ancestor objects due to the properties
of independence. For a visual realisation of a Bellman-Harris process see Figure 18.
We outline the formal definition described in Bellman-Harris [Harris, 1964] Chapter 6. We firstly
define a set of unique identifiers for objects in the branching process. Suppose 〈x〉 = 〈x1, x2, ..., xk〉 is
a finite collection of ordered integers with x1, x2, ..., xk ∈ N>0 and k ∈ N≥0. Let us define X as the
collection of all possible 〈x〉s. Note X also includes the empty set. Let us denote the ancestor object as
〈∅〉. Let us denote the ancestor’s first child as 〈1〉, its second child as 〈2〉 and so on. In general, indexed
object 〈x1, ..., xk−1〉 has its xkth child denoted as 〈x1, ..., xk−1, xk〉. Because all children appear at the
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same time, there is no significance of first, second or third child etcetera; these numbers merely act as
unique identifiers.
To fully define a specific family history of a branching process, we need to assign lifetimes and
numbers of offspring to each object. For each object 〈x〉 ∈ X let us assign it two values: its
lifetime j〈x〉 ∈ R≥0 and the number of offspring it has upon death h〈x〉 ∈ N≥0. We define a
family history ω as the collection of all these values for j〈x〉 and h〈x〉 for each 〈x〉 ∈ X, w =
(j〈∅〉, h〈∅〉, j〈1〉, h〈1〉, j〈1, 1〉, h〈1, 1〉, j〈2〉, h〈2〉, ...). Let us denote the complete collection of all fam-
ily histories as Ω. We note that if, for example, h〈x1, ..., xl〉 = k then child 〈x1, ..., xl, k + 1〉 is never
born and so j〈x1, ..., xl, k + 1〉 and h〈x1, ..., xl, k + 1〉 are redundant information contained in ω.
We want to introduce a probability measure P on the space of all family histories Ω. We do
this by defining a probability measure on each of its elements. Let us introduce a set of random
variable J〈x〉 : Ω → R≥0 for each 〈x〉 ∈ X such that J〈x〉(ω) = j〈x〉. Let us say the set of random
variable J〈x〉 are i.i.d. and identically distributed to a random variable J having some distribution
P (ω ∈ Ω : J(ω) ≤ t) = P (J ≤ t) = FJ(t). We assume FJ(t) to be any probability distribution with the
properties FJ(0−) = 0 and FJ(0+) < 1. Likewise, let us introduce a random variable H〈x〉 : Ω→ N≥0
for each 〈x〉 ∈ X such that H〈x〉(ω) = h〈x〉. We say all H〈x〉s are identically distributed to a random
variable H with the distribution P (ω ∈ Ω : H(ω) ≤ h) = P (H ≤ h) = FH(h). The random variables
H〈x〉 are i.i.d. and independent of the random variables J〈x′〉s for all 〈x〉, 〈x′〉 ∈ X.
Each ω in Ω now corresponds to a denumerable family of independent random variables. [Kol-
mogorov, 1933, Ch. 4] gives us that a denumerable set of independent, real valued random variables
determine a unique countable additive probability measure P on measurable sets in Ω.
To define a random variable for the population at time t under this probability measure, let us first
define a function that designates if an object is alive. The function a(〈x1, ..., xk〉, ω, t) : X×Ω×R≥0 → Z
is defined as
a(〈x1, ..., xk〉, ω, t) =

1, if x1 ≤ h〈∅〉 and x2 ≤ h〈x1〉 and x3 ≤ h〈x1, x2〉... and xk ≤ h〈x1, ..., xk−1〉
and j〈∅〉+ j〈x1〉+ ...+ j〈x1, ..., xk−1〉 ≤ t
and j〈∅〉+ j〈x1〉+ ...+ j〈x1, ..., xk−1〉+ j〈x1, ..., xk〉 > t.
0 otherwise
This means a(〈x〉, ω, t) = 1 if object 〈x〉 is alive at time t for a family history ω. Let us define a
function Z(ω, t) : Ω× R≥0 → Z as
Z(ω, t) =
∑
〈x〉∈X
a(〈x〉, ω, t).
Z(ω, t) is the count of all objects alive at time t for family history ω. As Z(ω, t) is a measurable
function on Ω ([Harris, 1964, Ch. 6.4]), we define Z(t) : Ω → N≥0 using the probability measure
defined by P over Ω, so that Z(t) as a random variable, representing the number of objects alive at
time t, with the distribution P (ω ∈ Ω : Z(t, ω) ≤ z) = P (Z(t) ≤ z) = FZ(t)(z).
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Figure 18: Simulated example of a Bellman-Harris process. Dots indicate an object’s birth,
horizontal lines indicate a an object’s lifetime, vertical lines connect siblings and crosses show death
without offspring. In this case, an object’s lifetime, J , is uniformly distributed between one and two.
For the offspring distribution, H, there is a 0.6 chance for the object to divide into two objects upon
death and a 0.4 chance for the object to die without offspring.
4.2.2 Results from a Bellman-Harris process
Supposing we have a defined Bellman-Harris process and want to find summary statistics, such as
expected value for the total number of objects at any time t. We do this by deriving relationships for
the generating function GZ(t)(s) via the total expectation theorem.
For any specific time t, we partition what may happen into two scenarios: either the original object
〈∅〉 has ended its lifetime by time t or it has not. We use the law of total expectation to split the
generating function into these two cases:
GZ(t)(s) = E(sZ(t)) = sP (J〈∅〉 > t) + E(sZ(t)|J〈∅〉 ≤ t)P (J〈∅〉 ≤ t). (6)
When an object ends its life at a time u it has a number of new offspring distributed identically to H
and the independence property allows us to treat each new object as a fresh Bellman-Harris process
with t− u time to divide before time t. Using this property, we adapt the right hand size of Equation
6 and get
GZ(t)(s) = sP (J > t) +
∫ t
0
GH(GZ(t−u)(s))dP (J ≤ u). (7)
This gives us an integral equation for the generating function of Z(t) ([Harris, 1964, Ch. 6, Th. 7.1])
and is known as a non-linear Volterra integral equation. A proof for the uniqueness and existence
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for the solution can be found in [Harris, 1964, Ch. 6.9]. If J is exponential random variable, this can
be solved explicitly due to the memoryless nature of the exponential function. There is no closed form
in general for other cases, but results can be achieved by numerical analysis and general asymptotic
results can be established.
4.2.3 Bellman-Harris process: The exponential case
In the case of exponential lifetimes J with parameter λ so that FJ(t) = 1− e−λt, by differentiating
7 with respect to t, the integral equation is rearranged to a differential equation ([Harris, 1964, Ch. 6,
Th. 11.1]):
dGZ(t)(s)
dt
= λ(GH(GZ(t)(s))−GZ(t)(s)). (8)
We are able solve this for a given offspring distribution H. For example, if every object has probability
1− p to divide into two cells and p to die without offspring, then
GH(s) = (1− p)s2 + (p). (9)
Substituting (9) into (8), solving the differential equation and using that GZ(0)(s) = s gives the solution
for the generating function for Z(t) as
GZ(t)(s) =
s
(1− p)s+ (1− s− ps)eλt .
Differentiating the generating function with respect to s evaluated at time s = 1 gives us
E(Z(t)) = eλ(1−2p)t.
and we can perform analogous calculations for other moments.
4.2.4 Multi–type Bellman-Harris process
The Bellman-Harris process can be expanded to include multiple types of object with different
lifetime distributions and offspring distributions. This is outlined briefly in [Harris, 1964, Ch. 6.28.3],
which we explain in this chapter. As in the single case we define the process informally and then
formally.
In the previous case, all objects in the process had the same lifetime and offspring distributions,
but let us assume in the new process, all objects belong to one of r different types (r ∈ N>0), and each
type has different properties. To define the process we must say what objects are alive at time zero,
so let us say there is one object alive of type q, with q = 1, . . . , r (as in the single case this is easily
expanded to cases beginning with more than one object). We randomly assign this object a lifetime.
At the end of the object’s lifetime, it has a random number of children of type one, another number of
type two and so on up to type r. We also assign random lifetimes to these new objects and they also
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have a random number of children of different types upon their death and so this process continues.
The lifetime random variable of each object of type i is independent all other objects’ lifetimes and
identically distributed to a random variable Ji that takes non negative values on the real line. Also
the distribution of number of offspring, which can be thought of as a r length vector of non negative
integers for each object type that are independent of each other and identically distributed to some
distribution, Hi. These distributions also independent of the lifetime distributions. Figure 19 shows a
visual realization of a multi-type Bellman-Harris Process.
We define the set 〈x〉 ∈ X as we did in Section 4.2 and again use these as unique identifiers for
objects in families. We then seek to define an array of independent random variables to each object
to indicate its lifetime and offspring as we did in the single case. However these random variables now
need to be of higher dimensions to represent the cases of the object being any of the r types.
For each object 〈x〉 we assign it a random lifetime if it is type one, j1〈x〉 ∈ R>0, another for
if it is type two, j2〈x〉 ∈ R>0, and so on, up to r. We arrange these in a r length vector in Rr
and call it ~j〈x〉. We also define h(i,k)〈x〉 ∈ R≥0 as the number of children of k type the object
〈x〉 has if it is as a i type object. We define ~h(i)〈x〉 ∈ Rr≥0 as an r length vector of with it’s kth
component corresponding to h(i,k)〈x〉. We assign r of these vectors to each 〈x〉 for the case of 〈x〉
parent itself being each of the r types, and we and arrange these in a r × r matrix in Rr×r>0 and call it
hr×r〈x〉. Then for each 〈x〉, ~j〈x〉 and hr×r〈x〉 Thus under this convention a family history is defined
by w = (~j〈∅〉, hr×r〈∅〉,~j〈1〉, hr×r〈1〉,~j〈1, 1〉, hr×r〈1, 1〉,~j〈2〉, hr×r〈2〉, ...) with Ω as the space of all ωs.
There is redundant information here as only the information relevant to the object 〈x〉’s actual type
will be used.
Let us introduce a set of random variable ~J〈x〉 : Ω→ Rr≥0 for each 〈x〉 ∈ X such that ~J〈x〉(ω) = ~j〈x〉.
This is as we did for the single case except that this is a vector of independent random variables. We
likewise do this for Hr×r〈x〉 : Ω→ Rr×r≥0 for each 〈x〉 ∈ X such that ~Hr×r〈x〉(ω) = ~hr×r〈x〉. So now each
ω in Ω corresponds to a denumerable family of independent random variables and so we can define a
countable additive probability measure P on measurable sets in Ω.
We wish define a function that maps a object 〈x〉 to its object type when given a family history
ω and a starting object of type q, ni(〈x〉, ω, q) : X × ω × N>0 → N>0. This function will also return
zero if the object does not exist. Let us first define g(〈x〉) : X → N0 to be the number of objects
in 〈x〉, which is the same as the generation and define a function s(〈i1, ..., ik〉) : X → X to remove
the last ordered object in a sequence, i.e. s(〈i1, ..., ik〉) = 〈i1, ..., ik−1〉 except in the case of the
ancestor object where s(〈∅〉) = 〈∅〉, thus s returns an object’s parent. We define a series of functions
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mi(〈x〉, ω, q) : X× Ω× N>0 → N>0 for i = 0, 1, 2.... Define m0(〈x〉, ω, q) = q. Then for i > 0
mi(〈x〉, ω, q) =

0, if mi−1(s〈x〉, ω, q) = 0 or h(v,1)〈s〉+ h(v,2)〈s〉+ ...+ hv,r)〈s〉 < xk
1, if h(v,1)〈s〉 ≥ xk
2, if h(v,1)〈s〉 < xk and h(s(x),2)〈s〉 ≥ xk
3, if h(v,1)〈s〉+ h(v,2)〈s〉 < xk and h(v,3)〈s〉 ≥ xk
...
r, if h(v,1)〈s〉+ h(v,2)〈s〉...+ h(v,r−1)〈s〉 < k and h(v,r)〈s〉 ≥ xk
where v = mi−1(s〈x〉, ω, q) . Then we then define n(〈x〉, ω, q) = mg(〈x〉)(〈x〉, ω, q), thus giving us a
function that returns the type of a object. The function m0(〈x〉, ω, q) is measurable and by induction
all mi(〈x〉, ω, q) are measurable.
We wish to define random variable for the population of objects of type b at time t under the
probability measure we defined over Ω, let us first define a function that designates if an object is alive
of type b. The function a(〈x1, ..., xk〉, ω, q, b, t) : X× Ω× N2>0 × R≥0 → Z is defined as
a(〈x1, ..., xk〉, ω, q, b, t) =

1, if n(〈x〉, ω, q) = b
and j〈∅〉+ j〈x1〉+ ...+ j〈x1, ..., xk−1〉 ≤ t
and j〈∅〉+ j〈x1〉+ ...+ j〈x1, ..., xk−1〉+ j〈x1, ..., xk〉 > t.
0 otherwise
This means a(〈x〉, ω, q, b, t) = 1 if object of type b, 〈x〉 is alive at time t for a family history ω. Let us
define a function Z(ω, q, b, t) : Ω× N2≥0 × R≥0 → Z as
Z(ω, q, b, t) =
∑
〈x〉∈X
a(〈x〉, ω, q, b, t).
Z(ω, q, b, t) is the count of all objects of type b alive at time t for family history ω given a the
ancestor object was of type q. Since Z(ω, q, b, t) is a measurable function on Ω, we again define
Z(q, b, t) : Ω→ N≥0 using the probability measure defined by P over Ω, so that Z(q, b, t) as a random
variable, representing the number of objects of type b alive at time t when the ancestor object is q,
with the distribution P (ω ∈ Ω : Z(ω, q, b, t) ≤ z) = P (Z(q, b, t) ≤ z) = FZ(q,b,t)(z).
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Figure 19: Simulated example of a multi–type Bellman-Harris process. Dots indicate object
birth, the colour of dots indicate object type, horizontal lines indicate object lifetime, vertical lines
connect siblings, and crosses show death without offspring. Green objects have lifetime uniformly
distributed between one and two. At the end of their lifetime, there is a 0.6 chance for the green
object to divide and a 0.4 chance for the object to become two blue objects. Blue objects have a
lifetime distributed uniformly between 0.25 and 0.5. Upon the end of their lifetime, blue objects can
either give birth to two blue objects with 0.5 chance or die without offspring with 0.5 chance. Due to
the unidirectional object differentiation in this case, looking only at green objects is an example of a
single–type Bellman-Harris process.
4.2.5 Results for the multi-type Bellman-Harris process
Let us suppose we have a multi-type Bellman-Harris process with two types of objects: one and
two. Supposing we assume the population starts at t = 0 with an object of type one. We want to find
the generating function of Z(1, i, t) for i = 1 and i = 2. We apply the same technique as in the single
type case to get an integral equation
GZ(1,1,t),Z(1,2,t)(s1, s2) = E(s
Z(1,1)(t)
1 s
Z(1,2)(t)
2 ) (10)
= s1P (J1 > t) +
∫ t
0
GH1(GZ(1,1,t),Z(1,2,t)(s1, s2), GZ(2,1,t),Z(2,2,t)(s1, s2))dP (J1 ≤ u) (11)
However, now this equation is dependent on GZ(2,1,t),Z(2,2,t)(s1, s2), the generating function for the
case when we start with a one object of type two. However, similar to the type one case, we have
GZ(2,1,t),Z(2,2,t)(s1, s2) = s2P (J2 > t)+∫ t
0
GH2(GZ(1,1,t),Z(1,2,t)(s1, s2), GZ(2,1,t),Z(2,2,t)(s1, s2))dP (J2 ≤ u)
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Solving this pair of integral equations will provide the generating function. This technique can be
expanded for any r number of object types to get a series of integral equations that need to be solved.
4.2.6 Example of a multi–type Bellman-Harris process
Let us assume that the lifetimes are exponentially distributed for each object type and this dis-
tribution is parametrised by λi for each object type i, FJ(t) = 1 − e−λt. As for the single case, this
allows for rearrangement into a series of differential equations. Let us find these differential equations
for the moments of a specific example, one similar to that of the optimal model described in [Buchholz
et al., 2013]. In this case, for objects of type i = 1, ..., r − 1, upon the end of their lifetime, each have
a 1− pi chance to divide, that is, become two objects of i type, and a pi chance to differentiate, with
one offspring of i+ 1 type. For the final object type r, division is certain at the end of the object’s life.
Under these conditions, the case of starting with an object type r, reduces to the single case.
Therefore, the generating function for this case can be found using techniques described in Section
4.2.3. Suppose we already have an equation for the generating function for the case of starting with
a single kth object at time zero, that is GZ(k,1,t),...,Z(k,r,t)(s1, ..., sr), and we want to calculate the
equivalent of this for starting with the (k− 1)th object. We have an integral equivalent to (10) for the
(k − 1)th generating function, but we substitute the solution to the kth object generating function in.
We then have an integral equation with only one unknown function, which can be solved. Therefore,
we can calculate generating function of a family tree starting from object type one by iteration.
Solving for the generating function itself can be extensive. If we just want to calculate the moments,
we can use differentiation and substitution to get a series of differential equations. Below are differential
equations that can be solved trivially for r, and then iteratively for the other cases. (φ(X) = E(X2)−
E(X) so requires one extra step to obtain the moment.)
dE(Z(k, i, t))
dt
= λk(1− 2pk)E(Z(k, i, t)) + λkpkE(Z(k − 1, i, t))
dφ(Z(k, i, t))
dt
= λk(1− 2pk)φ(Z(k, i, t)) + λkpkφ(Z(k − 1, i, t)) + 2λk(1− pk)E(Z(k, i, t))2
dE(Z(k, i, t)Z(k, v, t))
dt
= λk(1− 2pk)E(Z(k, i, t)Z(k, v, t))
+ λkpkE(Z(k + 1, i, t)Z(k − 1, v, t) + 2λk(1− pk)E(Z(k, i, t)Z(k, v, t))
These equations allow for a simpler means to calculate the summary statistics of mean, variance and
covariance of different object types. However, when looking into models with more than three types,
even in this simple case of linear object differentiation, the computations get more laborious with
solutions running into tens of lines.
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4.3 How the Bellman-Harris process is used in [Buchholz et al., 2013]
The paper [Buchholz et al., 2013] has observed summary statistics of means, variances and co-
variances for CD8+ T cell families, eight days after infection split by three proposed phenotypes of cen-
tral memory precursor (TCMp; CD27+CD62L+), effector memory precursor (TEMp; CD27+CD62L-)
and effector cells (TEF; CD27-CD62L-). See Section 3.2 for information on how these data are ac-
quired. [Buchholz et al., 2013] looks to see if these summary statistics contain a footprint that gives
information as to how the immune response works. To this end, [Buchholz et al., 2013] defines a set
of parameterised models as follows (see diagram 20):
• Within each model are four types of cell: Naive, TCMp, TEMp, and TCMp. There is one naive
cell alive at time zero.
• Lifetimes of cells are distributed exponentially and are identically distributed according to their
cell–type. Each of these exponential distributions need one parameter each and thus there are
four parameters needed to describe the distribution of all types of cells’ lifetimes.
• Upon the end of a cell’s life, there is a chance for each cell–type to divide (except the naive cell
which cannot divide) or differentiate into another cell-type (other cell-types cannot differentiate
into a naive cell). Possible differentiation between cell-types is known as a path. Different model
types have a different combination of paths open between cell types, and paths can be uni- or
bi-directional. There must be a direct or indirect path from the naive cell to each cell–type.
Thus, each path is another parameter on the model (minus one to account for the naive cell
having no probability divide). This describes 304 different models with between seven and 12
parameters.
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Figure 20: [Buchholz et al., 2013] model scheme allowing for all possible differentiation
pathways between phenotype subsets. Of the parameters, four (pink) determine the distribution
of the cell’s lifetime and eight (yellow) determine the distribution of a cell’s fate upon exiting its current
state. There are 304 models that can be constructed by closing permutations of different differentiation
pathways (i.e. fixing the probabilities of differentiation to zero or one), but leaving at least one path
(direct or indirect) from the naive cells to each of the subsets.
For each of the 304 models, [Buchholz et al., 2013] finds the relevant summary statistics for a given
parameterisation. [Buchholz et al., 2013] then measures the distance from these expected summary
statistics to the observed summary statistics using χ2 minimization, adjusted for degrees of freedom
where bootstrapping was used to acquire a sample variance required. Therefore [Buchholz et al., 2013]
has 304 objective functions for each of the models. For each 304 models [Buchholz et al., 2013] then
minimises using
“...both simulated annealing and a local optimization algorithm (trust-region-reflective
algorithm using Matlabs optimization toolbox) with at least 300 different random initial
values.[Buchholz et al., 2013, supplementary material page. 5]”
[Buchholz et al., 2013] repeats the fitting for different sets of summary statistics: in one case fitting
to mean, variance and covariance of phenotype populations on day eight, and in another case fitting
to the same data but including proportional phenotype data. They also separately rank each model
using both AICc and χ2 minimization adjusted for degrees of freedom which, in this case, reduce to
the same best fitting models. [Buchholz et al., 2013] uses the convention that an AICc of above ten
is unsupported by the model and, of those that remain, [Buchholz et al., 2013] excludes those that
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predict an absence of the TEMp subset in a certain threshold, 42%-56% in this case. The remaining
models are accepted as the best fit. Refer to Section 5.1.1 for a full description of results and our
recreation.
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5 Novel adaptation the fitting method to other data sets
Objective. The authors of [Buchholz et al., 2013] used a methodology of fitting probabilistic models
to observed clonal data in order to rank cell differentiation pathways during CD8+ T cell expansion
phase (Section 4.3). In this section we first recreate their results to establish that our implementation
of their method is correct (Figures 21, 22, 23). We adapt their method so that it can be applied to
statistics reported other papers. We first test this adaptation on the original data from [Buchholz
et al., 2013] and then apply it to [Kinjyo et al., 2015] and [Schlub et al., 2010] to see if the resulting
best fitting model changes.
Fitting to proportions. The adaptation of the methodology to new data requires the removal
of dependency on statistics that can only be determined from clonal data. We recreate the [Buchholz
et al., 2013] methodology, but fitting to the reported cohort data (reported proportions of phenotypi-
cally defined cell types at different times), which is more readily available in other papers.
We establish that fitting the model to cohort data gives essentially the same result as when fit-
ting to the clonal statistics, the best fitting probabilistic model being Naive → CD62L+CD27+ →
CD62L-CD27+ → CD62L-CD27-. We also see a similar best fitting parameterisation (Figures 23, 24,
25, 26). This leads to the deduction that in some circumstances, fitting to cohort data is a reasonable
alternative to fitting clonal data, which is less widely available.
Adjusting to data reported in other papers. To be able to apply the [Buchholz et al.,
2013] method to other data sets requires further changes. We change the objective function from a
χ2 to a weighted MSE, in order to remove dependency on sample variance. We reduce the number
of phenotypes to two, CD62L+ and CD62L-, thus removing dependency on CD27. This reduces
the models to two: a Linear Memory First Model or a Linear Effector First Model (Figure 27),
representative of those described qualitatively in Section 3.1.
Taking data from the paper as-is and using this adapted method we find, consistent with the
conclusions of the respective papers, that [Buchholz et al., 2013] data fits best to a Linear Memory
First Model, whereas [Kinjyo et al., 2015] data fits the best to a Linear Effector First Model (Figure
33).
Adjusting for experimental differences. The number of T cells adoptively transferred in these
experiments are different: 102−104 cells transferred in [Buchholz et al., 2013] and 106 in [Kinjyo et al.,
2015] (see Chapter 3). The papers [Schlub et al., 2010] and [Badovinac et al., 2007] both observed a
shortened expansion phase for experiments with high adoptive transferred numbers, such as those in
[Kinjyo et al., 2015] (Figures 28, 29, 32). As a result, the naive application of the [Buchholz et al.,
2013] methodology, which is conditioned on asking when memory occurs should it occur during the
expansion phase, to the [Kinjyo et al., 2015] data is inappropriate as this likely includes a contraction
phase. When this is adjusted for, the [Kinjyo et al., 2015], [Buchholz et al., 2013] and [Schlub et al.,
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2010] data all fit best to a Linear Memory First Model (Figure 33, 34, 35) under the assumption of
the method. The best fitting parameterisations to [Kinjyo et al., 2015] data shows few memory cells
appearing during the expansion phase. This, along with evidence presented in the [Kinjyo et al., 2015]
paper itself, such as a subset of slowly proliferating cells of memory phenotype appearing after the
end of the expansion phase (day four-five in their case), may suggest the assumption memory appears
during the expansion phase could be challenged.
As a second, more minor point, we suspect the cells [Buchholz et al., 2013] reported as TCMp type
also include cells that would traditionally be described as naive (Baars et al. [2005]) and we adjust for
this in the method. This does not change the best fitting model to [Buchholz et al., 2013] data.
Headline result. Initially, the papers [Buchholz et al., 2013] and [Kinjyo et al., 2015] have apparent
contradictions, this is both in the conclusion the papers come to themselves and our analysis on their
data. However, correcting for the number of adopted cells transferred changes this. If all assumption of
the method are true and memory is made during the expansion phase, then the [Buchholz et al., 2013]
methodology consistently supports a memory first path of differentiation above an effector first path
when fitting to all blood and spleen data. If memory is made after the expansion phase is complete,
as the [Kinjyo et al., 2015] data seems to suggest is possible, then [Buchholz et al., 2013] cannot speak
for this possibility.
5.1 Recreating [Buchholz et al., 2013]
5.1.1 Amendments to [Buchholz et al., 2013] fitting methodology
We recreated results of the model fitting method as described in [Buchholz et al., 2013] with some
simplification and changes.
Firstly, [Buchholz et al., 2013] fits to the 304 probabilistic models to find the best fitting model (Sec-
tion 4.3 for a full description of these models). We fit the data to a small subset of these. Specifically,
we only fit linear models, i.e. models were there is a single uni-directional path between phenotypes
(Figure 21). We index the six permutations of these models for brevity:
• Model 1: Naive → CD62L+CD27+ → CD62L-CD27+ → CD62L-CD27-
• Model 2: Naive → CD62L+CD27+ → CD62L-CD27- → CD62L-CD27+
• Model 3: Naive → CD62L+CD27- → CD62L+CD27+ → CD62L-CD27-
• Model 4: Naive → CD62L+CD27- → CD62L-CD27- → CD62L+CD27+
• Model 5: Naive → CD62L-CD27- → CD62L+CD27+ → CD62L+CD27-
• Model 6: Naive → CD62L-CD27- → CD62L-CD27+ → CD62L+CD27+
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Model 1 is that which [Buchholz et al., 2013] reported as one of the two best fitting of the 304 models
they tested.
For each model, the first cell-type that a naive cell differentiates to we denote as cell-type two,
the second cell-type in the linear differentiation path is denoted type three and the third is denoted
as cell-type four. Each cell-type requires a parameter to define its lifetime distribution which we
denote as: λN , λ2, λ3, λ4. The probability a cell-type two differentiates upon exiting its current state
is denoted p23 and the probability cell-type three differentiates is denoted p34. Cell type four is
terminally differentiated cell and can only divide. Thus, for each model we have parameters ~θ ∈ R6,
~θ = (λN , λ2, λ3, λ4, p23, p34).
We numerically attempt to identify the ~θ that minimises χ2(xˆ, ~x(~θ)) using the method described in
Section 4.3. Since all models have the same number of parameters, we ae able to rank them with a χ2
objective function directly.
TYPE 2Naive
TYPE 2
TYPE 2
TYPE 2 TYPE 3
TYPE 3
TYPE 3
TYPE 3 TYPE 4
TYPE 4
TYPE 4
TYPE 4
λ2λN λ3 λ4
p23 p34
1-p23 1-p34
MODEL INDEX TYPE 2
PHENOTYPE
TYPE 3
PHENOTYPE
TYPE 3
PHENOTYPE
MODEL 1 CD62L+CD27+ CD62L–CD27+ CD62L–CD27–
MODEL 2 CD62L+CD27+ CD62L–CD27– CD62L–CD27+
MODEL 3 CD62L–CD27+ CD62L+CD27+ CD62L–CD27–
MODEL 4 CD62L–CD27+ CD62L–CD27– CD62L+CD27+
MODEL 5 CD62L–CD27– CD62L+CD27+ CD62L–CD27+
MODEL 6 CD62L–CD27– CD62L–CD27+ CD62L+CD27+
1. Naive cells live a exponentially 
distributed lifetime parameterized by 
λN. Upon death they become cells of 
type two. 
2. Type two cells live an exponentially 
distributed lifetime parameterized by λ2
Upon death, type two cells differentiate 
into cells of type three with probability 
p23 or divide into two type two cells with 
probability 1-p23.
3. Type three cells live an exponentially distributed 
lifetime parameterized by λ3. Upon death, type 
three cells differentiate into cells of type four with 
probability p34 or divide into two type three cells 
with probability 1-p34.
4. Type four cells live an exponentially 
distributed lifetime parameterized by λ4. 
Upon death type four cells always divide 
into two type four cells.
Figure 21: Index for six linear differentiation models being fitted to. These models are a
subset of the 304 Bellman-Harris processes modelled by [Buchholz et al., 2013] and described in Section
4.3. Each of the six models has six parameters, ~θ = (λN , λ2, λ3, λ4, p23, p34).
[Buchholz et al., 2013] does not explicitly state if these parameters are bounded during their opti-
misation routine. We assume λN , λ2, λ3, λ4 ∈ {x ∈ R|0 < x ≤ 3}, as it is biologically implausible for
a cell to take less than eight hours to divide on average ([Hawkins et al., 2009],[Kinjyo et al., 2015]).
We also take p23, p34 ∈ {x ∈ R|0 < x < 1}.
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For each model, when minimizing the objective function we use the python library scipy.optimize.
minimize. We use 50 starting locations (~θ0) randomly selected by uniform distribution between the
boundaries of each parameter. For parameters that must be strictly between their bounders and not
on them, we allow these parameters to takes values up to three significant figures from that boundary.
[Buchholz et al., 2013] uses 300 starting points and does not explicitly state how they are randomly
chosen. For each starting point we repeat the data fitting with two different algorithms: Truncated
Newton Algorithm (TNC,Nash [1985]) and Sequential Least Squares Programming Algo-
rithm (SLSQP ,[Nocedal and Wright, 2006, Ch. 18]) and take the minimum of them both.
5.1.2 Result of the recreation of [Buchholz et al., 2013] fitting
The results matched [Buchholz et al., 2013] when fitting models to mean cell counts, variances
and covariances. We find that Model 1 (CD62L+CD27+ → CD62L-CD27+ → CD62L-CD27-) is the
best fit model to the data, as the authors of [Buchholz et al., 2013] found. We also find a similar
parameterisation for the best fit as seen in Table 5 and Figure 22. The slight differences are explained
by the fact that both the observed statistics and the [Buchholz et al., 2013] best fit parameterisation
we compared to were read manually off graphs (supplementary material S26, S17 and respectively,
Figure 4E reported the proportional data).
Parameter A. Value read from
[Buchholz et al., 2013]
B. Recreated value us-
ing [Buchholz et al.,
2013] method
λ−1N (days) 0.41 0.34
λ−12 (days) 0.95 1.03
λ−13 (days) 0.69 0.66
λ−14 (days) 0.63 0.63
p23 0.19 0.15
p34 0.03 0.03
Table 5: Best fitting parameters described in [Buchholz et al., 2013] compared with
parameters we derive for Model 1 (CD62L+CD27+→CD62L-CD27+→ CD62L-CD27-).
[Buchholz et al., 2013] parameters were read from a graph in the supplementary material S17. The
parameterisation is similar between the two best fitting models.
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Figure 22: Statistics from the for Model 1 (CD62L+CD27+→CD62L-CD27+→
CD62L-CD27-) using [Buchholz et al., 2013] best fit parameterisation (dashed line) and
a recreated best fit parameterisation (solid line). Statistics shown are: A mean cell count, B
coefficients of variation, C correlation coefficients and D phenotype proportions. Observed data (dots)
are taken from data graph points in [Buchholz et al., 2013] supplementary material S26. Error bars
show the standard error of the mean. The statistics are similar between the two best fitting models.
5.2 Adapting the model fitting methodology described in [Buchholz et al.,
2013] to work with proportional data
5.2.1 Changing objective function
To transfer the methodology as developed for clonal data to one suitable for cohort data, we repeat
the methodology described in Section 5.1, but instead of fitting to the mean cell count, variance and
covariance of the three phenotypes, we fit to the proportions of the three phenotypes observed on day
one, two, three, four, six and eight post infection reported in [Buchholz et al., 2013], and also fit to
the average size of a clonal family at day eight. This last statistic is required as otherwise the fitting
will have no concept of scale. Thus the observed statistics will be defined as xˆ ∈ R19.
Because we are looking at proportional data at different times, we have a new data set in addition
to that of the data set O47×3 we defined in Section 4.1. Each of these new data points we denote as
qt,i,j , which are counts of cells of phenotype i (i ∈ {2, 3, 4}), in replicate experiment j (j ∈ {1, ..., 47})
harvesting at time period indexed as t (t ∈ {1, ..., 6}) post infection. The data set of all such points we
consider a matrix Q6×47×3 ∈ R6×47×3. Thus the vector of summary statistics are defined by a function
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~s : O47×3 × Q6×47×3 → R19 and for brevity we denote xˆ = ~s(Om×n × Q6×47×3). The observed data
Q6×47×3 is at a population level (from multiple transferred progenitor cells per mouse) and the cell
counts are not absolute because they do not take into account cell loss during the counting process.
We only require one statistic using the data Om×n, which is the average total family size at day
eight post infection, which we denote as xˆ1 given by
xˆ1 = s1(Om×n ×Q6×47×3) = 1
47
47∑
i=1
oi,1 + oi,2 + oi,3.
The 18 average phenotype proportion statistics are defined as
xˆ(3t+i−2) = s(3t+i−2)(Om×n ×Q6×47×3) = 1
47
47∑
j=1
qt,j,i
(qt,j,1 + qt,j,2 + qt,j,3)
for t = 1, ..., 6 and i = 1, 2, 3.
These 18 statistics do not incorporate elements of Om×n.
We also require the equivalent model statistics, ~x(~θ), to compare the estimates xˆ to. Recall from
Section 4.2.4 that if we have in a multi-type Bellman-Harris process and at time zero we have a single
cell of type 1 (naive), we denote as the expected number of cells of type j at time t as E(Z(1, j, t)).
The model statistic for average family size at day eight, i.e x1, is
x1 = E(Z(1, 2, 8)) + E(Z(1, 3, 8)) + E(Z(1, 4, 8)). (12)
Because we do not have the raw data we cannot calculate the SEM of the total population directly, but
can approximate it by assuming independence and summing the SEMs of the individual phenotype
populations. The naive cell data are not reported in [Buchholz et al., 2013] and for this calculation
they are assumed to be excluded from the observed statistics.
Let tj be the times post infection observed statistics were measured in [Buchholz et al., 2013] indexed
by j, with j = 1, .., 6, that is t1 = 1, t2 = 2, t3 = 3, t4 = 4, t5 = 6 and t6 = 8. Then the proportional
model summary statistics we wish to compare to observed statistics are defined as
x(3k+j−2) =
E(Z(1, j + 1, tk))
E(Z(1, 2, tk)) + E(Z(1, 3, tk)) + E(Z(1, 4, tk))
for k = 1, .., 6 and j = 1, 2, 3. (13)
We then find numerically arg inf~θχ
2(xˆ, ~x(~θ)) via the methods described in Chapter 4.
5.2.2 Naive cell classification in [Buchholz et al., 2013]
The authors of [Buchholz et al., 2013] observed three phenotypes within their experiment and
assigned each of these a cell-type: CD62L+CD27+ cells were labelled as TCMp cells, CD62L-CD27+
cells were labelled as TEMp cells and CD62L-CD27- cells were labelled as TEF cells. However, there
were four cell types within the suggested model, the forth being the naive cells, and there were no
reported statistics for observations of naive cells after infection. This could be interpreted two ways:
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• that naive cells have been excluded from the data and thus ignored during the model fitting,
• or naive cells were included in the count of the other phenotypes.
Equations 12 and 13 assume the first interpretation.
Whichever of these interpretations is correct has negligible impact on statistics taken on day eight.
This is because for the average number of naive cells in a family must be less than one and thus would
have small impact on the large populations of cells seen on day eight. Also, biologically plausible
models should have the majority of naive cells activated at the time of peak immune response. Thus,
this ambiguity would have a small effect on the results when using the methodology described by
[Buchholz et al., 2013]. However, if naive cells were included in another phenotype, this may have a
significant impact on the proportional statistics observed at earlier time points in the immune response,
when total populations are lower and many naive cells are still not differentiated.
Naive cells have a high expression of CD62L, however reports of CD27 expression on naive cells
have been conflicted (Hendriks et al. [2000], Baars et al. [2005], [Kinjyo et al., 2015]) and papers have
reported on now naive cells are often mis-categorised as memory cells (Murali-Krishna and Ahmed
[2000]). [Buchholz et al., 2013] themselves define naive cells as CD62L+ CD27+ ([Buchholz et al.,
2013] Supplementary Figure 3), but with a different gating strategy than used for the classification of
other cell types ([Buchholz et al., 2013] supplementary Figure 22). It is therefore plausible that naive
cells are counted within the reported TCMp (CD62L+CD27+) count in [Buchholz et al., 2013].
We wished to see how the results would be affected if we changed the proportional fitting method
to account for this. Let us suppose within the linear model for CD8+ T cell expansion described in
Section 5.1.1, the TCMp cells are the ith cell-type in the linear differentiation path, with naive cells
being cell-type one and with the ith type being either two, three or four. So using the notation as in
Equation 13 but with naive cells being counted in the ith phenotype, model proportional summary
statistics are calculated as
x(3k+j−2) =
E(Z(1, j, tk))
E(Z(1, 1, tk)) + E(Z(1, 2, tk)) + E(Z(1, 3, tk)) + E(Z(1, 4, tk))
when i 6= j
x(3k+j−2) =
E(Z(1, 1, tk)) + E(Z(1, j, tk))
E(Z(1, 1, tk)) + E(Z(1, 2, tk)) + E(Z(1, 3, tk)) + E(Z(1, 4, tk))
when i = j,
for k = 1, .., 6 and j = 1, 2, 3.
The model statistic for total average family size at day eight, i.e x1, is also changed to
x1 = E(Z(1, 1, 8)) + E(Z(1, 2, 8)) + E(Z(1, 3, 8)) + E(Z(1, 4, 8))
although this will have small impact. We then fit these new model statistics to their respective observed
statistics as before.
Throughout the rest of this chapter, unless otherwise stated, we assume that naive cells are included
in the TCMp count. An analysis of the impact of assuming the alternative are considered in Appendix
C.1.
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5.2.3 Results of fitting to cohort data
Using the methodology of fitting models to cohort data, we found Model 1 (CD62L+CD27+ →
CD62L-CD27+ → CD62L-CD27-) to be the best fit, as was the case when using clonal data to fit.
If we take the data as-is, and adopt the assumption that naive cells were excluded from the reported
data, as opposed to naive cells included within TCMp cell counts, the conclusion of Model 1 being the
best fit is stronger than the original fit to clonal data, with Model 1 having an objective function for
its best fitting parameterisation being fifty times lower than any other model (Appendix Figure 40).
For a more detailed analysis on the results using this different assumption see Appendix C.1.
When assuming naive cells are included with the counts of TCMp cells, we reach the same conclu-
sion, with Model 1 being the best fit. Thus, we find Model 1 is clearly the best fit and results are the
same regardless of which assumption is taken. This suggested that fitting to cohort data could be an
appropriate alternative to fitting to clonal data. The parameterisation for the best fitting model was
similar in both the original and adjusted method for five parameters out of six, as shown in Figure 24.
The difference in the parameter λN , which parametrises the lifetime of naive cells, could be explained
by the fact that the adjusted method compares the sum of proportions of naive and TCMp cells to
one statistic, the proportion of CD62L+CD27+ cells, so that while the model is able to fit well to
the portion of the sum of the two cell types, it is not able to discriminate between their separate
contributions. Models one showed a good fit visually when comparing model and observed phenotype
proportions (Figure 25). The returned statistics of the best fitting model were also visually similar
between the original and adjusted method as seen in Figure 26, further supporting that fitting to clonal
or cohort data produces similar results.
The magnitudes of the objective function for the cohort fit are larger than that of objective function
for the clonal fit. One factor that explains this is there are nine observed statistics to fit to when
fitting to means variances and covariances against 19 when fitting to cohort data. Also, the sample
variances are smaller for the proportion statistics and so errors between observed and model statistics
are penalised more. Thus it is not appropriate to compare the absolute values of two different objective
functions for the same model, rather we should compare two different models using the same objective
function.
Together, these results suggest that for this model the fitting to proportional data with an average
family size is a reasonable alternative to fitting to the mean count of cells, variances and covariances.
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Figure 23: The objective function value for the best fitting parameterisations of the six
linear models when fitting to observed statistics of mean cell count, variances and co–
variances as in [Buchholz et al., 2013] (green, as in Section 5.1.1) compared with fitting
to proportion data and average family size (blue). Smaller values indicate a better fit. Model
1 (CD62L+CD27+→CD62L-CD27+→ CD62L-CD27-) is the best fitting in both cases, however fitting
to population data rather than clonal reduces the strength of this result.
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Figure 24: The best fitting parameters derived by fitting against means of cell count,
variances and co-variances alongside parameters from fitting to proportional data and
average family size for Model 1 (CD62L+CD27+→CD62L-CD27+→ CD62L-CD27-). The
parameters are similar between the two best fitting models with the exception of λN .
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Figure 25: Proportions and average family size of phenotype of best fitting parameter-
isation for each of the six linear models. Dashed lines show when fitting to mean cell counts,
variances and covariances and solid lines shows when against proportional data and average family size.
Observed data (dots) was taken from data graphs in [Buchholz et al., 2013] supplementary material S26.
Error bars show the standard error of the mean. Only Model one (CD62L+CD27+→CD62L-CD27+→
CD62L-CD27-) fits well visually to the observed data when fitting to clonal data.
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Figure 26: Statistics from Model 1 (CD62L+CD27+→CD62L-CD27+→ CD62L-CD27-)
for the best fit parameterisation fitting to mean cell count, variances and covariances
(dashed line) compared with fitting to proportional data and average family size at dif-
ferent times (solid line). Statistics shown are: A mean cell count, B coefficients of variation, C
correlation coefficients and D phenotype proportions. Observed data (dots) were taken from data
graphs in [Buchholz et al., 2013] supplementary material S26. Error bars show the standard error
of the mean. The statistics are similar between the two best fitting models with the exception of
the CD62L-CD27- variance and its covariance to CD62L+CD27+. Both fits assume naive included in
CD62L+CD27+.
5.3 Further adaptations to method
5.3.1 Changing the weighting of the objective function
The χ2 objective function that [Buchholz et al., 2013] used to rank models required estimates of
the sample variance (σ2xi) for each observed statistic, as defined in Section 4.1.2. However, the paper
[Kinjyo et al., 2015] reports only the proportional statistics and thus there is not sufficient data to
make the bootstrapping calculation for their sample variance. Therefore we need to select a different
objective function not dependent on this missing data.
A simple MSE objective function is not appropriate. This is because differences in scale between
the total population statistics and the proportional statistics will lend heavy weighting the population
statistics.
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It is possible to apply a weighting to the MSE to correct for this. One possibility is weighting each
element of the sum by the inverse of the observed statistic squared. This would weigh the percentage
difference between any two statistics equally. We denote the objective function WMSE1, defined as
WMSE1(xˆ, ~x(~θ)) =
19∑
i=1
(xˆi − ~xi(~θ))2
xˆi
2 . (14)
This objective function has some disadvantages. It is not defined if any element of xˆ takes the value
zero, thus we redefine the domain WMSE1 : R19>0 × R19 → R. However this is not such an issue for
this thesis as all proportional statistics within in [Buchholz et al., 2013] are greater than zero. This
objective function will heavily weigh absolute differences between statistics that are close to zero.
Alternatively, we use another WMSE where we only divide one of the sum’s elements by the
respective observed statistic squared, the observed populations at day eight post infection. We leave
the proportional statistics not weighted. We denote this objective function WMSE2 as
WMSE2(xˆ, ~x(~θ)) =
(xˆ1 − ~x1(~θ))2
xˆ1
2 +
19∑
i=2
(xˆi − ~xi(~θ))2 (15)
This still has the issue that the total population at day eight cannot be zero, WMSE2 : R>0×R37 → R.
It also arbitrarily weights statistics in a different ways, but does reduce the issue of proportional
statistics having heavier weightings as they approach zero. From henceforth in this thesis unless
otherwise stated we use the WMSE2 objective function. We did an evaluation of the effects of using
the WMSE1 objective function and the same results were reached. Detailed analysis is available in
Appendix C.2.
5.3.2 Reducing the number of phenotypes
While the [Kinjyo et al., 2015] does have some CD27+ data it is not in a format we can use for
this analysis. What [Kinjyo et al., 2015] does provide is the percentage of CD62L+ cells at different
times post infection. We convert the data in [Buchholz et al., 2013] to this format by adding their
CD62L+CD27- proportional data to their CD62L+CD27+ proportional data to get the proportion of
CD62L+ cells post infection as seen in Figure 16. Thus we have two sets of simplified data of the same
format.
These data are not compatible with the current method or objective function. We seek to define
a new set of models that do not distinguish between CD27- and CD27+ cells so that we can fit the
observed statistics without this information. We change the assumption that there are four underlying
cell types: naive, TCMp, TEMp and TEF used in [Buchholz et al., 2013] to three cell types: naive,
memory and effector cells with naive and memory having a CD62L+ phenotype and the effector cells
having a CD62L- phenotype (Figure 27).
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TYPE 2Naive
TYPE 2
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TYPE 2 TYPE 3
TYPE 3
TYPE 3
TYPE 3
λ2λN λ3
p23
1-p23
MODEL INDEX NAÏVE PHENOTYPE TYPE 2 PHENOTYPE TYPE 3 PHENOTYPE
LINEAR MEMORY FIRST CD62L+ CD62L+ CD62L–
LINEAR EFECTOR FIRST CD62L+ CD62L– CD62L+
1. Naive cells live a exponentially 
distributed lifetime parameterized by 
λN. Upon end of this state they 
become one cell of type two. 
2. Type two cells live an exponentially distributed 
lifetime parameterized by λ2. Upon exit from this 
state, type two cells differentiate into one cell of 
type three with probability p23 or divide into two 
type three cells with probability 1- p23.
3. Type three cells live an 
exponentially distributed 
lifetime parameterized by λ3. 
Upon exit from this state type 
three cells always divide into 
two type three cells.
Figure 27: Description of the two simplified linear differentiation models being fitted to.
These models are a simplified version of those described in Figure 21, with the observed phenotypes re-
duced from three (CD62L+CD27+, CD62L+CD27-, CD62L-CD27-) to two (CD62L+, CD62L-) and cell
types being reduced from four to three. This simpler model has four parameters, ~θ = (λN , λA, λB , p23).
This new model is a multi-type Bellman-Harris process that follows a linear unidirectional differen-
tiation path, analogous to the previous one described in Section 5.1.1. The first cell-type that a naive
cell differentiates to we denote as cell-type two, the next cell-type in the linear differentiation path is
denoted type three. Each cell-type requires a parameter to define its lifetime distribution which we
denote as: λN , λ2, λ3. The probability a cell two differentiates upon exiting is denoted p23. Cell-type
three is terminally differentiated cell and can only divide. Thus there are four parameters for each
model (λN , λ2, λ3, p23).
There are two possible versions of this model: either cell-type two has a CD62L+ phenotype and
cell-type three has a CD62L- phenotype or the reverse is true. These models are specific mathematical
versions of the biological models of Effector First or Memory First described in Chapter 3 and we label
them as such:
• Linear Memory First Model differentiation path: Naive → CD62L+ → CD62L-
• Linear Effector First Model differentiation path: Naive → CD62L- → CD62L+
We calculate the models proportional summary statistics using the method described in Chapter 4
but for a three type Bellman-Harris process. The objective functions are equivalent to those defined
earlier as WMSE1 and WMSE2 (equations 14 and 15), with the only change being the number of
proportional statistics fitted to. In the case of [Buchholz et al., 2013] there is one observed total
population statistic to map to at day eight (xˆ1) and two proportional statistics of each of the six time
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points xi, (i = 2, ..., 13). Thus the objective functions are defined as before but mapping from fewer
statistics WMSE1 : R13>0 × R13 → R and WMSE2 : R1>0 × R25 → R. When using this method on
[Kinjyo et al., 2015] data we note that there are two sets of four proportional statistics, so we redefine
WMSE1 : R9>0 × R9 → R and WMSE2 : R1>0 × R17 → R.
We then fit these two models to the summary statistics described in the papers [Kinjyo et al., 2015]
and [Buchholz et al., 2013] and find the parameterisation that returns the minimum objective function
value.
5.3.3 Predicting the day of peak immune response
An average mouse has around 100-1000 cells capable of responding to any specific antigen, meaning
large adoptive transfers, such as the 106 seen in [Kinjyo et al., 2015], dwarf the endogenous response
([Schlub et al., 2010]). Experiments have shown that the time an immune response peaks is inversely
related to the number of adoptively transferred cells in OT-1 experiments ([Schlub et al., 2010] and
[Badovinac et al., 2007]). While it is difficult to suggest a one size fits all number for the threshold
of cells than can be transferred without an abnormal response, [Badovinac et al., 2007] reports that a
5× 103 transfer still shows signs of abnormality in OT-1 models but 70 cells transferred did not. It is
important to know when the peak of the expansion phase is, as the mathematical model we employ
does not cover the contraction phase.
The papers [Schlub et al., 2010] and [Badovinac et al., 2007] both report the proportion of OT-
1 lymphocytes at different days post infection in experiments using different numbers of transferred
cells. We take the time the proportion OT-1 cells is at its maximum to indicate the peak of the
immune response. We use log-linear fitting to find approximate the relationship between the number
of transferred cells and an the day of peak response (Figure 28). For an experiment transferring 107
cells, as described in [Buchholz et al., 2013], we estimate the peak to be between seven and eight
days post infection. For an experiment transferring 106 cells, as described in [Kinjyo et al., 2015], we
estimate the peak day to be between day four and five.
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Figure 28: Day of peak response in experiments reported in [Schlub et al., 2010] and
[Badovinac et al., 2007] using different numbers of transferred cells. Log-linear regression
was used to find an estimate for the day of peak response (y co-ordinate) from the number of adoptively
transferred cells (x co-ordinate).
This estimate is based on specific assumptions. The time of peak immune response is taken to mean
when the proportion of OT-1 cells is at its maximum, as opposed to absolute cell count. Measurements
were not taken at every day post infection and therefore may be subject to censoring. It assumes a
log-linear relationship between adoptive transfer numbers and day of peak immune response is a good
one. This estimate returns a value for [Buchholz et al., 2013]’s experiment transferring 107 cells closest
to day seven, whereas the [Buchholz et al., 2013] model assumes a peak immune response at eight
days post infection. Due to the fact the [Buchholz et al., 2013] experiment is under the threshold for
number of adoptively transferred cells, and the fact the [Badovinac et al., 2007] experiment did not
take samples on day eight or nine, in effect censoring the data, we adopt the value used in [Buchholz
et al., 2013] that the expansion phase lasts at least eight days.
5.3.4 Predicting the average family size
The methodology of fitting models to observed cohort data also requires a fit to average family size
at peak immune response in order for models to scale correctly, however these data are not reported
in [Kinjyo et al., 2015]. Therefore, we need a way to estimate average family size value as a function
of the number of cells adoptively transferred. We note that while average family size has been shown
to be predictable in the immune response, we do expect individual family sizes to be heterogeneous
([Buchholz et al., 2013],[Gerlach et al., 2013]).
The authors of [Schlub et al., 2010] provide a methodology for calculating the relative difference in
the average number of divisions OT-1 transferred cells have taken by the time of peak response between
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two experiments (Appendix A). We use a similar method to find the relative number of divisions cells
take between the [Kinjyo et al., 2015] experiment and the [Buchholz et al., 2013] experiment, and thus
we are able to calculate an estimate for the average number of cells per family in the [Kinjyo et al.,
2015] data at the time of the peak immune response.
Let l equal the total number of lymphocytes in a mouse at peak immune response, c be the total
number of OT-1 cells transferred (the number of OT-1 families assuming no death), a be the size of an
average OT-1 family at peak response and o denote the proportion of OT-1 cells out of all lymphocytes
at peak response, then
o =
ac
l
. (16)
We would like an estimate for a. While c is known, o and l are not and we would like to derive an
estimate for them first. To this end we plot a log-linear scatter plot of the number of transferred cells
and the percentage of OT-1 lymphocytes at the peak of the immune response as reported in the data
from [Schlub et al., 2010] and [Badovinac et al., 2007]
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Figure 29: Proportion of OT-1 cells at peak response in experiments reported in [Schlub
et al., 2010] and [Badovinac et al., 2007] using different numbers of transferred cells.
Log-linear regression was used to estimate the percentage of OT-1 cells out of all lymphocytes at the
peak of the immune response. This estimate was used to determine the percentage of OT-1 cells at
peak response (y co-ordinate) from the number of adoptively transferred cells (x co-ordinate). We see
the numbers of OT-1 cells do not grow relative to the size of the adoptive transfer, thus average family
size is shrinking for higher transfers. The fact the log-linear line crosses the x-axis, shows this estimate
cannot be used for low transfer numbers, and this has a possible the explanation that low numbers of
adoptively transferred cells do not scale in the same way as high ones.
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This log-linear fit gives us the equations
o = 0.10log10(c)− 0.18. (17)
For the [Buchholz et al., 2013]’s adoptive transfer of 107 cells, we can calculate the expected percentage
of OT-1 cells using Equation 17 gives us the value 0.031 or 3.1%. Using this information along with
the average family size of OT-1 T cells at the peak of the immune response reported by that paper, we
use Equation 16 to calculate an estimate the total number of lymphocytes in a mouse in the [Buchholz
et al., 2013] experiment at peak infection,
l =
107× 15500
0.031
= 5.3× 107. (18)
We make the assumption that the total number lymphocytes at the peak immune response is the
same across all experiments, an assumption supported by spleen data in [Schlub et al., 2010]. However
[Badovinac et al., 2007] has spleen counts that suggest this may not always be the case, particularly
for low transfer numbers. Based on this assumption we get
a =
o× 5.3× 107
c
(19)
=
(.10× log10(c)− 0.18)× 5.3× 107
c
(20)
=
5.6× 106 × log10(c)− 9.6× 106
c
. (21)
Thus we have a estimate of the average size of a cell family at the time of peak immune response from
the number of cells adoptively transferred. We can use this to calculate estimates of different average
family sizes as reported in Figure 31 and Table 6. This estimate is only useful for adoptive transfer
of 100 cells or higher due to the estimate for OT-1 proportions against transfer numbers crossing the
x axis, as seen in Figure 29. We expected the method not to be appropriate for these small numbers
of transfers and this could be interpreted biologically; [Badovinac et al., 2007] reported the effect of
adoptive for 70 OT-1 cells less did not cause the average family size to shrink as did large transfers.
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Figure 30: For a given number of Ot-1 transferred cells, an estimate of their average
family size at peak immune response. For low numbers of transferred cells (<100) the estimate
is not good.
101 102 103 104 105 106
transfered number of cells
0
2
4
6
8
10
12
14
16
%
 o
f 
O
T
-1
 c
e
lls
 a
t 
p
e
a
k 
re
sp
o
n
ce
Estimate for [Badovinac et al. 2007]
Estimate for [Schlub et al. 2010]
Estimate for [Buchholz et al. 2013]
Estimate for [Kinjyo et al. 2015]
Figure 31: Estimated average number of division per cell at time of peak against adoptive
transfer size. Dots show an estimate based on percentage of OT-1 cells observed at a peak assuming
there are 5.3× 107 lymphocytes in total, the black line shows the estimate using equation 21. For low
numbers of transferred cells (<100) the estimate is not good.
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Paper c (obs) l (est) o (obs) o (est) a (est)
[Buchholz et al., 2013] 1.0× 102 5.3× 107 n/a .03 1.5× 104
[Buchholz et al., 2013] 107 5.3× 107 n/a .03 1.5× 104 (obs)
[Schlub et al., 2010] 3.2× 103 5.3× 107 .11 .18 3.0× 104
[Schlub et al., 2010] 1.6× 104 5.3× 107 .15 .26 8.4× 103
[Schlub et al., 2010] 8.0× 104 5.3× 107 .32 .33 210
[Schlub et al., 2010] 4.0× 105 5.3× 107 .34 .40 53
[Kinjyo et al., 2015] 1.0× 106 5.3× 107 n/a .44 23
Table 6: Observation and estimates of values in Equation 16 [Buchholz et al., 2013],
[Schlub et al., 2010], [Kinjyo et al., 2015]. c is the total number of cells transferred, l is the total
number of lymphocytes at the peak immune response, o is the proportion of all cells at peak immune
response, a is the average family size at peak immune response. est indicates an estimation and obs
indicates an observation.
This estimate is equivalent to saying [Kinjyo et al., 2015] cells, for a 1×106 size transfer, on average
went through 9 divisions less than that of [Buchholz et al., 2013], with a 1× 102 cell transfer (Figure
30). This roughly ties to the conclusion from [Schlub et al., 2010] that states that cells from a 4× 105
transfer go through approximately five less divisions on average than a 3.2× 103 transfer. From this,
and the fact that [Buchholz et al., 2013] reports a 15k (13.8 average divisions) average family size at
peak, we then calculate that in the [Kinjyo et al., 2015] experiment we would expect 23 cells per family
(four to five average divisions) at the peak of around day 4.5. This also is reasonable when compared
to [Badovinac et al., 2007]’s data, which reported that there is only a 13 fold increase in peak frequency
for a 10,000 fold increase in precursor transfer.
While relative numbers are comparable, large discrepancies in reported data for absolute cell counts
highlight caveats with these estimates. [Buchholz et al., 2013] reports a value of 15k for the average
peak family size (107 cells transfer) while [Badovinac et al., 2007] giving estimates of up to 400k family
size estimate for 50 cells transferred. Our estimate for the total number of lymphocyte cells in a mouse
(calculated from the [Buchholz et al., 2013] number) is lower than that [Schlub et al., 2010] reported
in the spleen by about four fold, and [Masopust et al., 2001] reports that total lymphocytes should
be at least double that in the spleen making eight fold difference between estimates. However for
high estimates comparisons are better, with [Badovinac et al., 2007] estimating a 40-400 peak average
family size for when transferring 5× 105 cells compared to our estimate of 43. Because of the fragility
of this estimate, we do a sensitivity test in Appendix B, which concludes that while average family size
does indeed effect the fit, it does not when limited the analysis to only biologically plausible models.
There are three main assumptions to this method: that the number of lymphocytes at the time of
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the immune response remains constant; the linear fit displayed in Figure 29 is a good estimate and
that our calculation estimating the day of peak of the immune response is a good one. For the first of
these assumptions we use evidence from [Schlub et al., 2010] and a similar assumption to theirs, that
the observed total lymphocytes counts in the spleen at peak immune response do not vary more that
6%. The log-linear assumption is used for simplicity, and noticeably predicts negative growth for low
numbers of OT-1 cells and so can only be useful above a threshold. We note the conflicting data on
the average family size make it difficult to reconcile all these problems of the estimate.
5.3.5 Results of adaptation to other papers data
CD62L+ T cell proportions reported in different adoptive transfer experiments show seemingly
conflicting trends up to day eight post infection (Figure 32). The data reported in [Buchholz et al.,
2013] shows a continual decrease in the proportion of CD62L+ cells up to day eight in the spleen, which
is consistent with their conclusion of effector cells out proliferating long lived memory cells late in the
expansion phase. The data reported in [Kinjyo et al., 2015] shows an initial decrease in proportions
of CD62L+, then a large increase before day seven post infection, consistent with their conclusion of
memory appearing later in the differentiation pathway. As seen in Section 5.3.3, a large number of
naive cells adoptively transferred can shorten the expansion phase, meaning some of data presented
in [Kinjyo et al., 2015] prior to day eight is likely to be after the expansion phase and therefore a
comparison should adjust for this. When the [Kinjyo et al., 2015] spleen data are curtailed to only
show the expansion phase, using the estimated peak of the immune response described in Section
5.3.3, the trends seen in papers [Buchholz et al., 2013] and [Kinjyo et al., 2015] are consistent, showing
percentage of CD62L+ cells to only decrease with time (Figure 32). This is confirmed by the [Schlub
et al., 2010] data, where data from experiments with high numbers of adoptively transferred cells show
an upturn in the proportion of CD62L+ cells before day eight, but this effect is absent if the data are
appropriately curtailed. Data from [Badovinac et al., 2007] follows this trend up to a point, but does
show an increase in the proportion of CD62L+ even after curtailing, though it is lessened. This was
also true for [Kinjyo et al., 2015] MLN data.
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Figure 32: Percentage of CD62L+ cells post infection reported in papers [Badovinac
et al., 2007], [Schlub et al., 2010] [Buchholz et al., 2013] and [Kinjyo et al., 2015]. The
top row shows all data reported up to day eight post infection, the bottom row shows the data only
during the experiments expansion phase. In the top row, experiments with high numbers of adoptively
transferred cells show a late increase in the proportion of CD62L+ cells, but when limiting the data to
only the expansion phase, as in the bottom row, the proportion of CD62L+ decreases only, with the
exception of some data from [Badovinac et al., 2007] and MLN data from [Kinjyo et al., 2015].
When fitting models to the [Buchholz et al., 2013] spleen cohort data, the Memory First Model was
marginally the best fit (Figure 33). When fitting to the [Kinjyo et al., 2015] spleen data up to day eight
post infection, the method found a Linear Effector First Model to fit best (Figure 33). The Linear
Effector First Model was also the best fit for experiments with high adoptive transfer numbers from the
blood data reported in [Schlub et al., 2010] (not curtailing data). Thus, when fitting without adjusting
for the number of cell adoptively transferred, we find contradicting results. For further breakdown of
the fit when not curtailing the data see Appendix C.3.
When we restrict the data from these three papers to the expansion phase, all data sets better
fitted the Linear Memory First Model, though some marginally (Figure 33). Some curtailed cohort
data (CD62L+ cell proportions harvested at different times post infection and estimated average family
size) from [Schlub et al., 2010] had less than four data points and so were not fitted to (8×104, 4×105).
While the results of the curtailed data consistently supported the Linear Memory First Model, the
strength of some results was low, particularly the result for [Kinjyo et al., 2015]’s curtailed data (Figure
33), where both models could be considered a good fit to the data. This is due to the fact that fewer
data points meant models found fitting easier and both models give good visual fits to the data (Figure
34).
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The parameterisation of the best fitting models when fitting to [Kinjyo et al., 2015] data showed
little memory appearing during the expansion phase: less than one cell per family (Figure 34 and 35).
For both the Memory First and Effector First Models, the curve of CD62L+ portions was primarily
made up for by the proportion of naive and effector cells only. This could suggest that the model is
not sophisticated enough or did not have enough data to fit to. An alternative explanation could come
from other [Kinjyo et al., 2015] results (Section 3.3), which showed a homogeneous population effectors
on day four post infection make way for two homogeneous groups of effectors and memory cells on
day seven. With the insight that day seven is after the expansion phase under the experimental setup
described in [Kinjyo et al., 2015], this result suggests the possibility that memory may appear in the
contraction phase. However, memory appearing in the expansion phase is an a core assumption of the
model, and this alternative is outside of the scope it can evaluate.
While models showed a good fit to the curtailed data, all best fits had biologically implausible
parameterisations, with naive cell average lifetimes being over 60 days, the only exception being the
Linear Memory First Model fitted to [Buchholz et al., 2013] data (Figure 35). Thus, for all other
models, the majority of naive cells were not activated at the end of the expansion phase and the
increase population was driven by a very small number of family’s that had activated and rapidly
expanded (Figure 34). This is at odds with results showing that, even for high adoptive transfers,
less than 0.1% of the OT-1 population comprised of unrecruited cells ([Schlub et al., 2010]) especially
since average family sizes are small for large transfers. In addition, data from [Kinjyo et al., 2015]
showed that no cells had divided on day two post infection yet the majority were preparing to divide,
suggesting the majority were recruited already. Other studies have shown that while high doses of
pathogens transferred lead to almost universal recruitment of nave cells, low numbers of transferred
pathogen can lead to only 30% or 50% recruitment ([Kaech and Ahmed, 2001]). There are reasons why
these experiments are not entirely comparable to the experiment we have looked at: the use of the P14
experimental model would have lower affinity than an OT-1 model, the difference in pathogen (Flu
vs LM, [Kinjyo et al., 2015]) may affect results, as could the metric used (pfu vs cfu). Nevertheless,
even in the low pathogen transfer cases seen in [Kaech and Ahmed, 2001], recruitment was shown to
be significantly higher than that seen in our parametrisations.
To see how the model ranking was affected by removing the possibility of the biologically implausible
number of non-activated naive cells, we redid the analysis, but upper bounding parameters so that
average cell lifetime is five days or less. When fitting with this method further adjusted, the expansion
phase the Linear Memory First Model was still was the best fit to all the curtailed data sets, but
the result was stronger, with the Linear Effector First Model failing to give a good fit for [Buchholz
et al., 2013] and [Kinjyo et al., 2015] data (Figure 36). In addition the parameterisations of the Linear
Memory First Model showed memory cells as longer living than effector cells in all cases as expected,
but this was not always true in the previous fits. This result showed us that under the assumptions of
the model, there was no biologically plausible good fit for the Linear Effector First Model when fitting
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against [Buchholz et al., 2013] or [Kinjyo et al., 2015] spleen data. For further breakdown of applying
the method with these extra parameter bounds refer to Appendix C.4.
Further CD62L blood data reported in [Badovinac et al., 2007] was also available to fit to (those
data sets that had at least three data points were for experiments with 5×102, 5×104 and 5×105 cells
transferred) and the MLN data reported in [Kinjyo et al., 2015] (1× 106) also had enough data points
to be able to fit to. This fit was done curtailing the data to the expansion phase and limiting the
parameterisation of the average cell lifetime to five days. The results (Figure 37) show all [Badovinac
et al., 2007] blood data continued to support a Linear Memory First Model. However some of these fits
had strange parameterisations with memory cells having shorter lifetimes than effector cells (Appendix
D). MLN data fitted best to a Linear Effector First Model, however these data are not appropriate to
fit to, due to the high migration of T cells to and from the lymph. For further analysis of these data,
the parameterisation and statistics, see Appendix D.
Thus when limiting blood and spleen data to the expansion phase, and limiting the parameterisation
of models to only biologically plausible cases, under the assumptions the the Linear Memory First
Model is the only viable option of the two models.
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Figure 33: The objective function value for the best fitting parameterisations of the
two simplified linear models when fitting to observed cohort statistics from different data
sources without assuming a shorted expansion phase (top) and with assuming a shortened
expansion phase (bottom). Smaller values indicate a better fit. [Buchholz et al., 2013] and [Kinjyo
et al., 2015] data from the spleen, [Schlub et al., 2010] data from the blood. After the data were
curtailed, two sets of [Schlub et al., 2010] data had less than four data points (including average family
size) and thus were inappropriate for fitting. When fitting to data up to day eight [Buchholz et al.,
2013] fits best to a Linear Memory First Model and [Kinjyo et al., 2015] to a Linear Effector First
Model. When the shortened expansion phase is accounted for, all models fit best to a Linear Memory
First Model. In this second case, the difference between the best fitting models for [Kinjyo et al., 2015]
is marginal.
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Figure 34: Statistics for the best fitting models when fitting to different sets of cohort
data from papers [Buchholz et al., 2013], [Kinjyo et al., 2015] and [Schlub et al., 2010].
Dashed lines show the Linear Memory First Model fits, solid lines show the Linear Effector First Model
fits, dots show the statistics from experimental data fitted to. The grey area shows the time after the
expansion phase has ended. Visual fits are similar between the two models when looking at proportions
of CD62L+ cells during the expansion phase when fitting to [Kinjyo et al., 2015] reported data. Only
the [Buchholz et al., 2013] data for the Linear Memory First Model shows the majority of naive cell
activated by the end of the expansion phase.
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Figure 35: Parametrization for the best fitting models when fitting to different sets of
cohort data from papers [Buchholz et al., 2013], [Kinjyo et al., 2015] and [Schlub et al.,
2010]. Parameters are as described in Figure 27. Only the memory first model fitted to [Buchholz
et al., 2013] data gives a biologically plausible result, the other models parametrise the naive cells
average time to activate as 60 days or more, which is not consistent with data indicating substantial
recruitment of T cells with cognate receptor ([Schlub et al., 2010],[Kinjyo et al., 2015]). In [Kinjyo
et al., 2015]’s case, for the Linear Memory First Model the effector cells live longer average lifetimes
than memory cells.
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Figure 36: The objective function values for the best fitting parameterisations of the two
simplified linear models when fitting to observed proportional phenotype statistics from
different data sources and assuming a shortened expansion phase. Smaller values indicate a
better fit. As in Figure 33 but upper bounding average cell lifetime to five days.[Buchholz et al., 2013]
and [Kinjyo et al., 2015] data from the spleen, [Schlub et al., 2010] data from the blood. This shows
strong results in favour of a Linear Memory First Model. After the data were curtailed, two sets of
[Schlub et al., 2010] data had less than four data points (including average family size) and thus were
inappropriate for fitting.
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Figure 37: The objective function values for the best fitting parameterisations of the two
simplified linear models when fitting to observed proportional phenotype statistics from
different data sources and assuming a shortened expansion phase. Smaller values indicate a
better fit. As in Figure 33 but looking at [Badovinac et al., 2007] blood data and [Kinjyo et al., 2015]
MLN data and upper bounded average cell lifetime to five days. [Badovinac et al., 2007] blood data
fitted best to a Linear Effector First Model, however [Kinjyo et al., 2015] MLN data fitted best to a
Linear Memory First Model, at odds with other blood and spleen data.
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6 Discussion
In this section we review and assess some of the assumptions necessary to the model. We suggest
further study to explore the problems tackled outside of these assumptions. Finally we draw together
conclusions, both from within the framework of the model and hypothetical ones.
6.1 Caveats of results and assumptions of the method
We reconsider model assumptions based on evidence of their likely truth and impact to core results.
Some of the assumptions we inherit from the methodology described in [Buchholz et al., 2013] and
others we found necessary as part of the adaptation of the mathematical model in [Buchholz et al.,
2013] to make it suitable for the more widely variable cohort data ([Kinjyo et al., 2015], [Schlub et al.,
2010]). Quantitative models often require strong assumptions to be mathematically well defined.
Assumptions were needed to reduce complexity and model parameters to avoid over-fitting to limited
data. Assumptions also come from difficulties in performing analysis across many different papers and
distinct data sets. In some cases it is difficult to assess the assumptions truth due to lack of evidence.
T cells’ lifetimes are exponentially distributed. Experimental in vitro evidence has shown
that there is a minimum time to divide and that cell lifetime distributions are closer to a log normal
distribution then an exponential one ([Dowling et al., 2014], [Dowling and Hodgkin, 2009]). This was
confirmed by the data from [Kinjyo et al., 2015]. However without an exponential distribution the
solution to the non-linear Volterra integral equation for the generating function of the population size
in a Bellman-Harris process, as in Equation 10, is non explicit and can be expressed in asymptotic
approximations. This leaves open further work of fitting the same models but with more realistic
lifetime distributions that are not memoryless.
Assumptions of independence and identically distribution for cell lifetime and/or off-
spring distributions. There is evidence that cell lifetime between sisters is correlated and however
lifetimes between cousins and mother-daughter lifetimes are not ([Kinjyo et al., 2015], [Hawkins et al.,
2009], [Markham et al., 2010], [Duffy et al., 2012], [Dowling et al., 2014]). There are many alternative
assumptions to distributions being i.i.d., for example distributions could change with time or activation
theory could mean clonal dependence ([Marchingo et al., 2014]).
Families of T cells behave independently. There are biological factors that could mean infor-
mation on one T cell families proliferation behaviour contains information on another within the same
organism. For example T cells use cytokines to communicate and it is possible environmental factors,
such as body temperature, affect T cell behaviour. The result that large adoptive transfers affect T
cell behaviour at a population level show that in some circumstances families are dependent.
Cell types are discrete and there are three-four of them. The traditional view, or accepted
approximation in the literature is that CD8+ T cells are compartmentalised into four sub-types: naive,
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effector, central memory and effector memory ([Sallusto et al., 1999], [Wherry et al., 2003], [Baars et al.,
2005]). To create a continuous model or assign new subtypes would be an undertaking outside the
scope of the present analysis, but would be of interest. The revised model we used employed an even
more simplified partitioning to three cell types: naive, memory and effector. This assumes effector and
effector memory cells have similar proliferation behaviour. We do this because of the difficulties in
building a more complex model on simple data and due to lack of data overlap when spanning different
papers.
Differentiation is not linked to division. Whether cells adopt cell types at the point they
divide or at some point mid their lifespan is difficult to determine, though there has been some
evidence supporting asymmetry theory ([Chang et al., 2007]). The assumption of the model described
in [Schlub et al., 2010] is that differentiation occurs at the point of division. The model described in
[Buchholz et al., 2013] took division and differentiation as two different events. It is possible to redefine
the mathematical model to have differentiation linked to differentiation. This would also allow us to
explore of the asymmetric hypothesis. We note that [Buchholz et al., 2013] reports some modelling
around asymmetric division and came to the same conclusion of memory appearing first.
No death during the expansion phase. The model used assumed no cell dies without out
offspring during the expansion phase. In general cell death is hard to measure, and particularly in
adoptive transfer because of difficulty in separating death during the expansion phase from death due
to the trauma of transfer. Some papers have shown evidence of cell death during the expansion phase
([White et al., 2015]). In future study, one could extend models to include a death parameter and use
AICc or otherwise to see if this parameter yields a much stronger fit.
Only linear paths considered. While [Buchholz et al., 2013] looked at many different network
structures, we only considered linear ones. This adapted model did include one of the two best fitting
parameterisations [Buchholz et al., 2013] found. It is possible that had non linear paths been in scope
these may have been the best fit to the data. As a future study it would be possible to extend the
model to these non linear cases.
Choice of objective function. The choice of objective function is subjective and depends on
different values of what it means for a model to be close to observed data. We tested the method
under a separate objective function and found the same result (Appendix C.2). Therefore the risk
is considered lower but there is always a possibility of another sensible objective function yielding a
different result.
Naive cells are CD27+. We assumed in that naive cells are CD27+. This assumption was only
necessary in the analysis of the cohort [Buchholz et al., 2013] data under the original model. While
reports agree there is some expression of CD27 on naive cells, data varies on whether CD27 in naive
cells is universally high or low compared to effectors (Hendriks et al. [2000], Baars et al. [2005], [Kinjyo
et al., 2015]). However the impact of this assumption being changed would lead to the same result of
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a memory first model fitting to the proportional data described in [Buchholz et al., 2013] data, but
more definitively, as seen in Appendix C.1.
The method for assuming day of peak immune response from numbers of adoptive
transferred cells is accurate. This method is described more fully in Section 5.3.3 and relies on
using a log-linear correlation to predict the day of peak immune response. As we used data from two
different experiments [Schlub et al., 2010] and [Badovinac et al., 2007] and found a good correlation
between them this gives us confidence that this is a reasonable estimator, but some margin of error is
possible. Some studies have also suggested that peak response time may be different between OT-1
cells and endogenous cells ([White et al., 2015]).
The method for estimating average family sizes at peak immune response from adoptive
transfer numbers is reliable. This method is described in Section 5.3.4. This method relies on the
assumptions that adoptive transfer numbers have a log linear correlation to OT-1 proportions at peak
of immune response and total T cells counts at the peak of an immune response are constant between
experiments. The first assumption was supported by a good correlation when comparing to two sets of
data. The second of these assumptions was evaluated and was shown to have evidence in its favour in
the [Schlub et al., 2010] paper, however some spleen data from [Badovinac et al., 2007] may contradict
this trend. Sensitivity analysis on the affects of assuming alternative average family sizes is done in
Appendix B.
Observations in specific parts of the body represent the whole. Where cells are harvested
from could have significant effect on the profile of T cells observed, both because of environmental
factors or because T cells are migrating around the body. CD62L itself is a homing receptor for the
lymph and so this may significantly effect results. [Buchholz et al., 2013] does a test that showed
numbers of OT-1 cells harvested from the spleen correlated to that of the spleen lung and lymph node
combined. In addition this test does not report phenotype correlation between the spleen and the rest
of the body. [Kinjyo et al., 2015] reports T cells in the lymph node proliferating faster than those in
the lungs and the spleen and that the MLN showed a much faster decrease in proportion of CD62L+
cells than the spleen. Therefore this is a significant assumption in our analysis, but one difficult to
overcome without a further experiments.
The OT-1 model is representative of a natural immune response. All experiments observe
the immune response of OT-1 cells to OVA antigen and it is assumed that these are representative of
a endogenous immune response. OT-1 cells react with a very high affinity to OVA and so therefore
may represent a stronger response than some endogenous responses. This result was confirmed by the
experiment described in the [Badovinac et al., 2007] paper using a P14 model.
CD62L is a good indicator of memory cell-type. CD62L correlating with other memory
characteristics is widely accepted in literature and sometimes CD62L even used in the definition of
memory itself ([Ahmed et al., 2009]). [Kinjyo et al., 2015] contains experiments showing how CD62L
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correlates to slow proliferation, [Buchholz et al., 2013] shows how it negatively correlates to effector
markings (KLRG1) and both [Badovinac et al., 2007] and [Schlub et al., 2010] show how it up regulates
during the death phase and effectors die off leave behind long lineage memory cells. However, it should
be noted that all these remain as correlations and so using one single marker yields a unknown amount
of false categorisation. Also, most experiments looking into memory and CD62L phenotype correlation
observe it late in the immune response. During the early days post infection (days one to three), when
the response is harder to measure in vivo, CD62L+ may include some naive cells or activated cells
that may be late down regulating their CD62L. it is worth noting CD62L- subgroup also contains
the effector memory subgroup which has some memory characteristics. While using a more in depth
method to define cell-type from multiple phenotypic traits seems ideal, this poses increasing difficulties
when trying to compare data across papers.
CD27 is a good indicator of effector and effector memory [Buchholz et al., 2013] used
CD27 to distinguish effector cell types from effector memory cell types. [Buchholz et al., 2013] shows
CD27- correlating with effector functionality and [Kinjyo et al., 2015] shows it correlating with higher
cell division speed. Other papers confirm this and correlate it to CD127 another marker of effector
functionality ([Sallusto et al., 1999], [Hendriks et al., 2000], [Baars et al., 2005], [Hikono et al., 2007]).
Experiments are comparable (e.g. the difference in gating strategy or pathogen used
are negligible). Both [Buchholz et al., 2013] and [Kinjyo et al., 2015] tested the effects of using
different pathogens or different quantities of antigen they found that this change did not strongly
effected results. Gating strategies are difficult to compare because they rely on relative setting of
individual flow cytometry machines.
All cell types appear in the expansion phase. The model we used assumed that memory
appeared during the expansion phase. One support of this assumption is that [Buchholz et al., 2013]
data showed all phenotypes had appeared by day eight post infection, though this could be explained by
gating. To counter this, [Kinjyo et al., 2015] showed T cell population was made up of a homogeneous
group of effector like cells up to the end of their expansion phase and then two heterogeneous groups of
cells after the expansion phase, one showing a memory phenotype and one showing a effector phenotype.
In addition the parameterisation of the best fitting model to [Kinjyo et al., 2015]’s data showed that
the proportion of CD62L+ cells could be explained by naive and effectors cells alone. This leaves the
possibility that this assumption is untrue.
Too few data points to fit to. For some data sets the model had few points to fit to. We worked
under the convention that the number of data points must equal or exceed the number of parameters
in the model. This included average family size which itself was an estimate. While [Buchholz et al.,
2013] had seven data points, [Kinjyo et al., 2015] and [Schlub et al., 2010] only had the minimum of
four. There was also a similar issue with the original method described in [Buchholz et al., 2013] where
the most complex networks had up to 12 parameters and had to fit nine data points.
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Human error in reading graphs and figures. The majority of data fitted to was taken visually
from graphs in papers and therefore could be subject to human error.
Difficulties in determining significance of results. There were many instances where we were
unable to determine significance. This was for two reasons: the data from papers often did not contain
enough information to calculate margin of errors; the mathematics of the model made computing the
probability density function difficult.
[Buchholz et al., 2013] used two different numbers in their cohort adoptive transfer
experiment: 1× 102(six, eight days p.i.) and 1× 104 (one-four days p.i.). We simplified this to say
that the expansion phase continued up to day eight as was the assumption in the [Buchholz et al.,
2013] paper itself.
6.2 Further work
There are opportunities to investigate the method of fitting the model described in [Buchholz et al.,
2013] to different data sets outside some of the assumptions listed above. The analysis in this thesis
was limited to linear unidirectional networks and it would be possible to expand this to all non-linear
networks as [Buchholz et al., 2013] did in the original method. Log-Normal cell lifetimes could be
assumed in which case the equations for the generation function of the population of a Bellman-Harris
process could be solved analytically. Sisters could be made to correlate in the model (e.g. [Duffy and
Subramanian, 2009]). The possibility of cell death could be included. Division could be linked to
differentiation and allow the possibility of asymmetric division.
Fitting to summary statistics of clonal data does not use all data extracted from experiments.
Theoretically it would be beneficial to fit mathematical models to distributions of clonal size. However,
there are obstacles to this approach, one is the computations of likelihood functions for multi-type
Bellman Harris processes are extensive and often approximations or assumptions are required ([Chen
and Hyrien, 2011]) which is likely why the papers themselves do not use this method. Another issue
with this method is that it is not possible to apply the method to experiments gathering evidence at
a cohort level such as [Kinjyo et al., 2015], [Badovinac et al., 2007] or [Schlub et al., 2010]. However,
opportunities to do some simplified version of distribution fitting in the future could be considered.
While we suggest the number cells adoptively transferred to be the main cause of differences in
results between [Kinjyo et al., 2015] and [Buchholz et al., 2013], it is worth considering alternate
hypotheses that we did not look at, but could be considered in future work ([Chamberlin, 1890]). For
example, the type of infection could play a role, as both experiments use different kinds of pathogens.
The flu used by [Kinjyo et al., 2015] is localized and less inflammatory when compared to the Listeria
monocytogenes used in [Buchholz et al., 2013]. However, investigation into this possibility would
require further experimental setups.
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Other possibilities for future work could include fitting a completely different mathematical model.
For example a mathematical model based around activation theory, such as the one describing T
cell populations in [Deenick et al., 2003]. In these models the behaviour of families is deterministic
after activation with heterogeneity of families arising from activation signalling or an internal random
variable decided at the start of the cells first division. So in this case random variables are assigned
to whole families rather than individual cells, meaning for instance, every single cell in a family has
the same time of division. This approach is supported by other recent papers ([Marchingo et al.,
2016],[Heinzel et al., 2017])
While the differences in most fits are seen to be large visually, it would be useful to test if they
are different in a statistical sense, particularly for more borderline results. This testing of statistical
significance is desirable and left for future work.
The method described in this thesis fits mathematical models to the expansion phase, however there
are other papers that fit mathematical models to both the expansion and contraction phase ([Antia
et al., 2005], [Ganusov, 2007]). The models these papers employed are different in a number of key
ways: they are fitted total average family size, not phenotype, and use a different parametrisation, for
example giving a decay parameter for the rate at which cells die. The paper [Ganusov, 2007] found the
Linear Effector First Model to give a reasonable parametrisation when fitted against observed data,
whereas the Linear Memory First Model did not give a reasonable parametrisation. This contrary to
our findings under different assumptions. Expanding the model we used to include the contraction
phase could be a source of further insight into the differences between methods.
Some models were able to better fit the data than others. It is useful to consider what qualitative
properties allow a model to fit well or poorly to different sets of data ([Ganusov, 2016]). We can
make certain broad comments, for example, a Linear Memory First Model can only fully match to a
decreasing function of CD62L+ over time as there is no way that the expected proportion of CD62L+
can increase, but this is not so with the Linear Effector First Model, which can show a later increase
in the proportion of CD62L+ (for example Figure 46). This explains why curtailing the CD62L data
when there was an late increase in CD62L+ had the effect of better fitting to the Linear Memory First
Model, and why the MLN data still fits best to the Effector First Model. We note the Linear Memory
First model may gain flexibility elsewhere, for example it has more ways to parametrize a delay in
CD62L- cells appearing than the Linear Effector First Model, which is more constricted, especially
when we put a cap of five days on a cell’s maximum average lifetime. Such observations are useful for
getting an intuitive view of which models we would expect to fit better than others, however getting
a comprehensive idea of what sets of results are likely to fit best to which model structures is left for
future studies.
Finally the mathematical model could be applied to analyse other data sets. While the [Buchholz
et al., 2013] fitted to clonal data, which is more difficult to acquire in vivo, we extended it to propor-
tional data. It is therefore possible apply the model to other data sets that have data on proportions
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of cells expressing different phenotype traits. It would be interesting to see if different markers or
combinations of markers yielded the same results. One possibility could be using the CD127 data from
[Badovinac et al., 2007] or [Schlub et al., 2010].
6.3 Conclusions
Firstly, we established that fitting the model to the cohort data reported in [Buchholz et al., 2013]
resulted in the same best fitting model and parameterisation as to clonal data. This showed fitting
to cohort data was a reasonable alternative in this instance. This is useful, as cohort data are more
readily available that clonal data and this lends credence to other models fitting to similar data sets
in the future. This finding also suggested robustness of the [Buchholz et al., 2013] conclusion under
their assumptions.
We also found an answer to question arising when questioning the apparent discrepancy in between
[Buchholz et al., 2013] and [Kinjyo et al., 2015]; these papers seemed to propose not just differing models
but differing results from a similar experiment. These different conclusions included the proportion of
CD62L expression and speed of proliferation in days one to seven of infection. Using the information
from [Badovinac et al., 2007] and [Schlub et al., 2010] we could explain some of the differences as arising
from the number of cells adoptively transferred and the fact this large transfer would cause a shorted
expansion phase in [Kinjyo et al., 2015]’s experiment. Under the adapted version of method described
in [Buchholz et al., 2013], whether or not we adjusted for the effects of a large adoptive transfers
returned fundamentally different conclusions. This might indicate a similar effect for other models,
qualitative or quantitative when comparing adoptive transfer experiments with different numbers of
cells transferred. Some papers listed in Table 3 used large numbers of transferred cells in experiments.
These included papers supporting the Effector First Model ([Opferman et al., 1999]: 5× 105− 2× 106
cells, [Jacob and Baltimore, 1999]: 2×105 cells) and the Asymmetric Model ([Chang et al., 2007]: 5×105
cells). This thesis further supports the notion that a large and small adoptive transfer experiments
may yield differing conclusions, and that some of the apparent contradictions or ambiguities around
questions of differentiation may arise if this difference in experimental set up is not considered.
Under the assumptions of the method, we found, the Linear Memory First Model is a stronger fit
to all blood and spleen data ([Badovinac et al., 2007], [Schlub et al., 2010], [Buchholz et al., 2013] and
[Kinjyo et al., 2015]) than the Linear Effector First Model. In addition, the best fit for the Linear
Effector First Model was biologically implausible with the majority of naive cells unactivated by the
peak immune response and was unable to give a reasonable fit when this possibility was not allowed.
This inference has some caveats: assumptions were strong and data points fitted to were sometimes
few ([Kinjyo et al., 2015] and [Schlub et al., 2010] after curtailing the data).
The MLN data set reported in [Kinjyo et al., 2015] supported the Linear Effector First Model under
the assumptions of the method. This conclusion could be drawn intuitively by looking visually at the
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proportion data fitted to (Figure 32), as there is sudden decrease, then later increase in CD62L+
after day two post infection and it is difficult to explain this late increase within a Linear Memory
First Model. This is at odds with the results in from the blood and spleen. This difference could be
explained a number of ways, it could be due to cell migration in the MLN, it may be the cause is that
the fitting method is not robust enough, that T cells behave fundamentally differently in depending
on their locations or that the large adoptive transfer size has cause strange differentiation dynamics
in the MLN. In addition we only had one data set from the MLN.
While these are the conclusions under the assumptions of the model, if we step outside those
assumptions we can suggest other possibilities.
One possibility is that memory arises after the expansion phase. This is given credence by the fact
that [Kinjyo et al., 2015] showing a memory subset appearing on day seven, which would be after the
expansion. In addition the parameterisation of the best fitting models suggested the curves of CD62L
during the expansion could be explained purely by effector and naive cell populations.
Another possibility is that while CD62L may correlate strongly with memory late in the immune
response, in the early days of an immune response it may not indicate memory as defined in the
classical sense and is mixed in with naivety.
Another possibility is the actual path is not a linear differentiation pathway, such as that seen in
asymmetry theory, and so was not evaluated.
In summary we find fitting mathematical models to CD8+ cohort expansion data a possible alter-
native to fitting to clonal data, we suggest cell transfer numbers to be a key difference between some
of the results in [Buchholz et al., 2013] and [Kinjyo et al., 2015]. Under the assumptions of the model,
our analysis support a Linear Memory First Model above a Linear Effector First Model for CD8+
differentiation pathways. However evidence from other papers and the parameterisation challenges
these assumptions and leaves open other possibilities.
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Appendices
A [Schlub et al., 2010]’s model for division estimation
In Section 5.3.4 we describe an estimate which we use to determine the average family size at the
peak of the immune response. In this appendix we discus the calculation this was adapted from,
described in the paper [Schlub et al., 2010]. The paper [Schlub et al., 2010] investigates whether there
is a link between the number of times a CD8+ T cell divides during the expansion phase and the
amount of CD62L it expresses. They do this via an adoptive transfer experiment described in Section
3.5. Using different frequencies of adoptively transferred cells they limit transferred colony growth.
They then measure the proportion of OT-1 cells out of total lymphocytes in a mouse (OT-1 being
donor cells progeny) and use these data to estimate the relative number of divisions an average T
cell takes under different assumptions of lymphocyte populations. They then see if they can find an
exponential correlation between the number of divisions and the proportion of CD62L+ cells.
Let us denote the population count of OT-1 T cells (donor cells) in the mouse for experiment i
at time t as oi(t), where t = 0 at the time of adoptive transfer. Let us also say ni(t) is the number
of non-OT-1 lymphocyte T cells in experiment i at time t (i.e. the endogenous cells). Let us denote
the average number of divisions an average T cell have gone through between two times t1 and t2 in
experiment i as di(t1, t2). For brevity we denote.
qi(t) =
oi(t)
oi(t) + ni(t)
. (22)
i.e as qi(t) as the proportion of OT-1 T cells at time t in experiment i. Assuming no cell death, we
can say
2d1(t1,t2)o1(t1) = o1(t2), (23)
which can be rearranged to give
d1(t1, t2) = log2
(
o1(t2)
o1(t1)
)
. (24)
However the absolute number of OT-1 T cells at a particular time in an experiment is often not known
(except at t = 0), but the proportion of OT-1 cells out of all T cells is reported in [Schlub et al.,
2010] and [Badovinac et al., 2007]. It is possible to get an estimate for d1(t1, t2) in terms of observed
proportions under different assumptions.
The authors of use a number of different methods to estimate the number of divisions between two
time points. We focus on that which method we adopt and adapt further. If we want to measure the
difference in number of divisions between two different experiments from the time of adoptive transfer,
we can use Equation 24 to get
d1(0, t1)− d2(0, t2) = log2(o1(t1)
o1(0)
)− log2
(
o2(t2)
o2(0)
)
. (25)
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Then, assuming o1(t1) + n1(t1) = o1(t2) + n1(t2), i.e. the total number of lymphocytes at the two
times is a constant we say,
d1(0, t1)− d2(0, t2) = log2
(
o2(0)p1(t1)
o1(0)p2(t2)
)
. (26)
Thus the relative difference in average number of division between two experiments can be calculated
from observable values. The assumption o1(t1)+n1(t1) = o1(t2)+n1(t2) is justified for the time of peak
response (not necessarily other time) from spleen data reported in [Schlub et al., 2010]. The authors
of [Schlub et al., 2010] used similar assumptions in the calculations to work out relative divisions
within or between experiments, and other assumptions include assuming the number of endogenous
cells remains constant between two time points (n1(t1) = n1(t2)).
B Sensitivity analysis on average family size
For all data sets other than that of [Buchholz et al., 2013], absolute count of average family size
was not reported in a way that we could incorporate into the fitting. We therefore used the estimate
described in Section 5.3.4 to determine of average family size at peak immune response. Because
this was only an estimate, we sought to investigate how sensitive the results in Section 5.2.3 were
to this calculation changing. Figures 38 show the results for the best fitting objective functions for
different values of the average population estimate, both for the Linear Memory First Model and
Linear Effector First Model. Figure 38 shows that average family size does effect results. For the
[Kinjyo et al., 2015] data, the Linear Memory First Model fits best excepting a window around 20
average family size (approximate), where both models are extremely close in terms of there objective
function. The data from [Schlub et al., 2010] showed that different assumptions for average family size
could return different best fit models. However, from results seen in Section 5.3.4, we suspected that
some of these best may parametrised with extremely long cell lifetimes that were biologically infeasible
leading to most naive cells being unactivated at the peak of the immune response. We repeated the
test, but capping the peak average cell lifetime to five days (Figure 39). In this case the linear memory
first model was stronger regardless of the assumption of family size, and this showed there was no
biologically plausible Linear Effector First Model that could fit well to these data sets.
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Figure 38: Objective function values when fitting models to data sets and varying the
the average family size assumed. The top graph shows the ratio of the the Linear Memory First
Model to the Linear Effector First Model (values under one indicate a better fit to the Linear Memory
First Model), and the bottom graph shows the absolute values for these two models (smaller values
indicate a better fit). Changing the assumed average family size does effect which model returns the
better fit.
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Figure 39: Objective function values when fitting models to data sets and varying the
assumption of the average family size and assuming the average cell lifetime cannot exceed
five days. The top graph shows the ratio of the the Linear Memory First Model to the Linear Effector
First Model (values under one indicate a better fit to the Linear Memory First Model), and the bottom
graph shows the absolute values (smaller values indicate a better fit). The Linear Memory First Model
fits better in all cases regardless of the assumed family size.
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C Changing assumptions in modelling
In Section 5 we adapted of the methodology described in [Buchholz et al., 2013] so that it could
be applied to cohort data. During this process we made a number of choices for our adaptations.
This appendix explores some of the results from using alternative assumptions when adapting the
model. We find the core result remains the same when these assumptions are changed: the Linear
Memory First Model fits best to all data sets when adjusting for the number of naive cells adoptively
transferred. However the strength of the result can vary, and under some assumptions both the Linear
Memory First Model and Linear Effector First Model give good fits to the data.
C.1 Changing classification of naive cells
The adaptation of the [Buchholz et al., 2013] method assumed the reported TCMp data in [Buchholz
et al., 2013] include cells that would classically be described as naive. This appendix looks at the
equivalent results if naive cells were assumed to be excluded from the data entirely.
In the case best fitting model is the same as in Section 5.2.3, i.e. Model 1 fits best (CD62L+CD27+
→ CD62L-CD27+ → CD62L-CD27-) (Figure 40). Under this new assumption Model 1 is also more
clearly the best fitting model than the original method. The parameterisation, visual fit and summary
statistics of Model 1 were are similar to the original method as seen in Figure 41, Figure 42 and Figure
43.
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Figure 40: The objective function value for the best fitting parameterisations of the six
linear models when fitting to observed statistics of mean cell count, variances and co–
variances as in [Buchholz et al., 2013] (green, as in Section 5.1.1) compared with fitting
to proportion data and average family size (blue). Smaller values indicate a better fit. This is
as in Figure 23 but assuming naive cells are not included in TCMp cells within [Buchholz et al., 2013]
reported data. Model 1 (CD62L+CD27+→CD62L-CD27+→ CD62L-CD27-) is the best fitting in both
cases.
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Figure 41: The best fitting parameters derived by fitting against means of cell count,
variances and co-variances alongside parameters from fitting to proportional data and
average family size for Model 1 (CD62L+CD27+→CD62L-CD27+→ CD62L-CD27-). As
in Figure 24 but assuming naive cells are not included in TCMp cells within [Buchholz et al., 2013]
reported data. The parameters are similar between the two best fitting models with the exception of
λN and λ2.
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Figure 42: Proportions of phenotype of best fitting parameterisations for each of the six
linear models. Dashed lines show when fitting to mean cell counts, variances and covariances and
solid lines shows when against proportional data and average family size. Observed data (dots) was
taken from data graphs in [Buchholz et al., 2013] supplementary material S26. Error bars show the
standard error of the mean. This is as in Figure 24 but assuming naive cells are not included in TCMp
cells within [Buchholz et al., 2013] reported data. Only Model 1 (CD62L+CD27+→CD62L-CD27+→
CD62L-CD27-) gives a good visual fit to the data.
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Figure 43: Statistics from Model 1 (CD62L+CD27+→CD62L-CD27+→ CD62L-CD27-)
for the best fit parameterisation fitting to mean cell count, variances and covariances
(dashed line) compared with fitting to proportional data and average family size at dif-
ferent times (solid line). Statistics shown are: A mean cell count, B coefficients of variation,
C correlation coefficients and D phenotype proportions. Observed data (dots) was taken from data
graphs in [Buchholz et al., 2013] supplementary material S26. Error bars show the standard error of
the mean. As in Figure 26 but assuming naive cells are not included in TCMp cells within [Buchholz
et al., 2013] reported data. The statistics are similar between the two best fitting models.
C.2 Changing objective functions
Because choice of objective function is always somewhat subjective we sough to investigate the
effects of a different objective function. Firstly, we reviewed the changes from the objective function
described in [Buchholz et al., 2013] to the adapted method described in Section 5. Graph 44 show the
ratio of the objective function of Model 1 to the other models for each step change of the adaptation.
It shows for all steps, Model 1 is the best fittings.
98
Model 1 Model 2 Model 3 Model 4 Model 5 Model 6
Model Index
0
1
2
3
4
5
6
7
M
o
d
e
l 
O
F 
S
co
re
 D
iv
id
e
d
 b
y
 
M
o
d
e
l 
1
 O
F 
S
co
re
 (
Lo
g
 V
a
lu
e
)
0.0
0.6
1.6
0.7
0.9
0.7
0.0
4.0
5.9
6.1
4.9
6.3
0.0
4.1
1.6 1.6
4.4
4.0
0.0
3.9
2.2
2.8
4.1
4.0
0.0
4.0
4.6
4.9
4.2
4.5
Fitting method:
1. [Buchholz et al. 2013] method
2. Fitting to proportional statistics
3. As in method 2. but including 
naive cells within the CD62L+ count
4. As in method 3. but using the 
WMSE objective function
5. As in method 4. but bounding 
above cell division time
Figure 44: Step changes to the objective function from the original method described in
[Buchholz et al., 2013] to the adapted version in Section 5.1.1. The above shows the ratio of
best fitting objective function values of the respective models to the best fitting objective function for
Model 1. Model indexing is described in Section 5.1.1. Model 1 is the best fitting in all cases. Smaller
values indicate a better fit and negative values (of which there are none) would indicate a better fit
than Model 1.
In Section 5.3.1 we defined the objective function WMSE1 as an alternative to the one we used
to do the analysis throughout detailed Section 5.3.5. We repeated the analysis using this alternative
objective function and came to the same conclusions: the Linear Memory First Model was the best
fitting, though it was in some cases close (Figure 45). This shows the robustness of results under at
least one different objective function.
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Figure 45: The objective function value for the best fitting parameterisations of the two
simplified linear models when fitting to observed cohort statistics from different data
sources with assuming a shortened expansion phase. Smaller values indicate a better fit. As in
Figure 33 but using the alternative objective function WMSE1 (defined in Section 5.3.1). All models
fit best to a Linear Memory First Model. In this second case, the difference between the best fitting
models for [Kinjyo et al., 2015] and [Buchholz et al., 2013] is marginal.
C.3 Removing transfer size adjustment
This appendix reports extra analysis on Figure 33 from Section 5.3.5. We fitted to the data as in
the adapted method, but without curtailing the proportional data in the expansion phase. In this case
the Linear Effector First Model fitted best for experiments with high numbers of adoptively transferred
cells and the Linear Memory First Model for low numbers (Figures 33, 46, 47). This highlights the
importance of curtailing the data to the expansion phase.
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Figure 46: Statistics for the best fitting models when fitting to different sets of data from
papers [Buchholz et al., 2013], [Kinjyo et al., 2015] and [Schlub et al., 2010] As in Figure
34 but not curtailing the data for the number of cells adoptively transferred. Dashed lines show the
Linear Memory First Model fits, solid lines show the Linear Effector First Model fits, dots show the
statistics from experimental data fitted to. The grey area shows the time after the expansion phase
has ended.
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Figure 47: Parametrization for the best fitting models when fitting to different sets of
data from papers [Buchholz et al., 2013], [Kinjyo et al., 2015] and [Schlub et al., 2010]
As in Figure 35 but not curtailing the data for the number of cells adoptively transferred. Parameters
are as described in Figure 27. Only the memory first model fitted to [Buchholz et al., 2013] data gives
a biologically plausible result. The other models parametrise naive cells living for an average of over
60 days or more.
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C.4 Changing the parameter boundaries
This appendix reports extra analysis on Figure 36 from Section 5.3.5. We repeated the fitting
method described in this section, but in order to remove the biologically implausible fits where most
naive cells had not activated by the end of the expansion phase we set a cap on average maximum cell
lifetime at five days. When curtailing the data to the expansion phase, the Liner Memory First Model
was best in all cases and had a much stronger result. This showed there was no biologically plausible
Linear Effector First fit to these data. All Linear Memory First Models had a good visual fit (Figures
48, 49). In all cases memory cell lifetimes were parametrised to be longer than effector cells.
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Figure 48: Statistics for the best fitting models when fitting to different sets of data
from papers [Buchholz et al., 2013], [Kinjyo et al., 2015] and [Schlub et al., 2010]. As in
Figure 34 but upper bounding average cell lifetime to five days. Dashed lines show the Linear Memory
First Model fits, solid lines show the Linear Effector First Model fits, dots show the statistics from
experimental data fitted to. The grey area shows the time after the expansion phase has ended.
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Figure 49: Parametrization for the best fitting models when fitting to different sets of
data from papers [Buchholz et al., 2013], [Kinjyo et al., 2015] and [Schlub et al., 2010]
As in Figure 35 but upper bounding average cell lifetime to five. The parameters are as described in
Figure 27.
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D Fitting to other data sets
This appendix reports extra analysis on Figure 37 from Section 5.3.5. Initially we fitted models to
spleen data reported in [Buchholz et al., 2013] and [Kinjyo et al., 2015] and blood data reported in
[Schlub et al., 2010]. After curtailing the data some of the [Schlub et al., 2010] data could not be fitted
to because of too few data points (less data points that parameters) so we fitted to other data sources
available.
[Badovinac et al., 2007] performed an adoptive transfer transfer experiment using 1×105, 2×105, 3×
105, 4 × 105 and 5 × 105 OT-1 cells and took blood samples at different days post infection. After
curtailing these data to the expansion phase using the method described in Section 5.3.3 we found
three of these data sets had the minimum number of data points to fit to. Another additional set of
data was reported in [Kinjyo et al., 2015], but for cells harvested from the MLN rather than the spleen
(transfer 5×105). This was not included in the main analysis initially because of migration. We fitted
models to these two data sets using the adapted method described in Section 5.3, both curtailing the
data and limiting average cell lifetime to a maximum of five days to avoid the non biologically viable
parameterisations seen in other data sets. This gave us the results reported in Figure 37. The blood
data from [Badovinac et al., 2007] fits best to a Linear Memory First Model, in keeping with the other
fittings to blood and spleen data seen in Section 5.3.The the 5× 105 fit is less strong and parametrises
for fast memory cells. The MLN data fits best to a Linear Effector First Model.
Figure 50 shows the summary statistics for these fits and Figure 51 shows their best fitting param-
eterisations. The [Kinjyo et al., 2015] lymph data fitting shows an increase in numbers of CD62L+
cells before the end of the expansion phase. The difference between MLN results and blood and spleen
results could be due to migration of T cells around the body or differences in the development of cells
at those locations. The high level of migration of the MLN data meant we did not include it in our
main analysis.
It is noticeable that the results on the [Badovinac et al., 2007] 5× 105 data set did not give a good
visual fit to the data for either model and also returned a strange parameterisation, where memory
cells have shorter lives than effectors. This could be due to problems with the model, or problems with
the data which can be seen to oscillate (Figure 32).
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Figure 50: Statistics for the best fitting models when fitting to different sets of data
from papers [Badovinac et al., 2007] blood data and [Kinjyo et al., 2015] MLN data. Data
curtailed to the expansion phase and parameterisation of average cell lifetime is upper bounded to five
days. Dashed lines show the Linear Memory First Model, solid lines show the Linear Effector First
Model, dots show experimental data fitted to. The grey area shows the time after the expansion phase
has ended. [Badovinac et al., 2007] data shows a better fit to the Linear Memory First Model whereas
[Kinjyo et al., 2015] MLN data better fits to a Linear Effector First Model.
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Figure 51: Parametrization for the best fitting models when fitting to different sets of
data from papers [Badovinac et al., 2007] blood data and [Kinjyo et al., 2015] MLN data.
The parameters are as described in Figure 27. Some parameterisations show memory having a shorter
average lifetime than effector cells. Lymph data are likely heavily effected by migration.
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